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Recent sequencing and assembly of the genome for the fungal pathogen Candida albicans used simple automated
procedures for the identification of putative genes. We have reviewed the entire assembly, both by hand and with
additional bioinformatic resources, to accurately map and describe 6,354 genes and to identify 246 genes whose
original database entries contained sequencing errors (or possibly mutations) that affect their reading frame.
Comparison with other fungal genomes permitted the identification of numerous fungus-specific genes that might be
targeted for antifungal therapy. We also observed that, compared to other fungi, the protein-coding sequences in the
C. albicans genome are especially rich in short sequence repeats. Finally, our improved annotation permitted a detailed
analysis of several multigene families, and comparative genomic studies showed that C. albicans has a far greater
catabolic range, encoding respiratory Complex 1, several novel oxidoreductases and ketone body degrading enzymes,
malonyl-CoA and enoyl-CoA carriers, several novel amino acid degrading enzymes, a variety of secreted catabolic
lipases and proteases, and numerous transporters to assimilate the resulting nutrients. The results of these efforts will
ensure that the Candida research community has uniform and comprehensive genomic information for medical
research as well as for future diagnostic and therapeutic applications.
Citation: Braun BR, van het Hoog M, d’Enfert C, Martchenko M, Dungan J, et al. (2005) A human-curated annotation of the Candida albicans genome. PLoS Genet 1(1): e1.
Introduction
Candida albicans is a commonly encountered fungal patho-
gen responsible for infections generally classed as either
superﬁcial (thrush and vaginitis) or systemic (such as life-
threatening blood-borne candidiasis) [1,2]. Its life cycle has
fascinating aspects that have generated great excitement over
the last decade, with an inﬂux of workers and new molecular
techniques brought to bear on long-standing problems [3].
Topics of particular interest are the organism’s capacity to
shift into several different phenotypic states, some with
distinct roles in infection, and its recently discovered capacity
to mate, providing at least part of a sexual cycle, although
population genetic studies indicate that it is still largely a
clonal diploid population. Other special adaptations for
infection include a battery of externally displayed proteins
and secreted digestive enzymes; complex interactions with
the host immune system normally keep C. albicans at bay as a
minor part of the mucosal ﬂora [1,4,5].
Here, we report a detailed annotation of the genome
sequence of this organism, bringing the previously available
raw sequence to a new level of stability and usability. The
genome of C. albicans has previously been shotgun sequenced
to a level of 10.9-fold coverage [6]. However the assembly of
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is diploid but with little or no gene exchange in the wild. Thus
homologous chromosomes show substantial divergence, and
many genes are present as two distinctive alleles. This
required that the assembly process be aware of the diploid
status and be prepared to segregate reads into two alleles for
any section of the genome. At the same time, the genome is
rich in recently diverged gene families that are easily
confused with alleles. This task was further complicated by
the absence of a complete physical map of the C. albicans
genome. Nevertheless, this arduous assembly process resulted
in a dataset (assembly 19, with 266 primary contigs over eight
chromosomes) that has already yielded a number of signiﬁ-
cant advances including the production of DNA microarrays
[7], libraries of systematic gene knockouts [8], large-scale
transposon mutagenesis [9], and the ability of many individ-
ual researchers to identify novel genes using bioinformatic
tools [10]. Unfortunately, due to the mostly computational
methods used in its development, the current genome
assembly still contains a signiﬁcant number of predicted
genes that are fragmented, overlapping, or otherwise erro-
neous. As a consequence, different groups have been using
different methods for the identiﬁcation and classiﬁcation of
C. albicans genes, which has hindered communication and
complicated comparisons between large-scale datasets.
Following the publication of these early functional ge-
nomics studies, it was realized that the needs of the C. albicans
research community would be better served by a uniﬁed gene
nomenclature. The results of this community-based effort
were initially based on the version 19 computational assembly
and preliminary annotation produced independently by
various research groups. We used visual inspection of
11,615 putative coding sequences and various bioinformatic
tools to reﬁne the quality and description of each open
reading frame (ORF).
In all, we provide unique identiﬁers, coordinates, names,
and descriptions for 6,354 genes. With the exception of
certain large gene families, we have not annotated the
portion of the assembly 19 DNA that was set aside as
secondary alleles, instead concentrating on the primary
sequence that forms one haploid genome equivalent. Inves-
tigation of the identity and relative divergence of all alleles
will be an important further project for the C. albicans
genome, as will ﬁnishing and linking the small number of
gaps that remain in the primary sequence. In addition, we
describe a variety of gene families and we discuss insights into
virulence. Finally, we use comparative genomics to point out
a variety of additional insights that are illuminated by the
high-quality annotation provided here. This project serves as
a model for community-based annotation that could be
applied by other research communities that wish to improve
on automated sequencing pipeline output that may be
available for their organisms of interest.
Results/Discussion
The Annotation Process
Compilation of Candida annotation data. As detailed in
Materials and Methods, we used assembly version 19 of the C.
albicans genome [6] to identify 11,615 putative ORFs. These
included genes encoding proteins greater than 150 aa as well
as genes encoding smaller proteins of 50–149 aa that have a
coding function greater than 0.5 as determined with a
GeneMark matrix [11]. These ORFs were then compared to
the set of 7,680 C. albicans ORFs deﬁned by the Stanford
Genome Technology Center (SGTC), thus permitting their
classiﬁcation using the same systematic identiﬁers of the
format orf19.n [6]. The 3,936 novel ORFs without an orf19.n
counterpart were assigned a new reference number of the
format orf19.n.i where orf19.n is the ﬁve-prime closest
(contig-wise) ORF deﬁned by the SGTC and i is an integer
that varies between one and the number of novel ORFs found
in the orf19.n to orf19.(nþ1) interval. To simplify correlation
with previously published data that use the orf6.n or earlier
nomenclatures, we have produced a Web-accessible trans-
lation tool (http://candida.bri.nrc.ca).
Positional information for each ORF was merged with data
from a variety of different sources, including the SGTC
(http://www-sequence.stanford.edu/group/candida/index.html),
CandidaDB (http://genolist.pasteur.fr/CandidaDB; [12]), the
Agabian laboratory (http://agabian.ucsf.edu/canoDB/
anno.php), and the Johnson/Fink laboratories [13], whose
annotation data had been updated with a Magpie annotation
[7]. This large dataset was then reformatted into EMBL-style
ﬁles, thus allowing for input in the Artemis annotation
software [14]. Volunteer annotators accessed a custom-made
database to reserve and download EMBL ﬁles containing
sequence and annotation data for each of the 266 DNA
sequence contigs. To help in validating various and some-
times conﬂicting sources of information, translated protein
sequences from putative C. albicans ORFs were compared to
putative protein sequences extracted from ﬁve fungal
genomes—Saccharomyces cerevisiae [15,16], Schizosaccharomyces
pombe [17], Neurospora crassa [18], Aspergillus nidulans (Aspergillus
nidulans Database, http://www-genome.wi.mit.edu/annotation/
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Synopsis
Candida albicans is a commonly encountered fungal pathogen
usually responsible for superficial infections (thrush and vaginitis).
However, an estimated 30% of severe fungal infections, most due to
Candida, result in death. Those who are most at risk include
individuals taking immune-suppressive drugs following organ
transplantation, people with HIV infection, premature infants, and
cancer patients undergoing chemotherapy. Current therapies for
this pathogen are made more difficult by the significant secondary
effects of anti-fungal drugs that target proteins that are also found
in the human host.
Recent sequencing and assembly of the genome for the fungal
pathogen C. albicans used simple automated procedures for the
identification of putative genes. Here, we report a detailed
annotation of the 6,354 genes that are present in the genome
sequence of this organism, essentially writing the dictionary of the
C. albicans genome.
Comparison with other fungal genomes permitted the identification
of numerous fungus-specific genes that are absent from the human
genome and whose products might be targeted for antifungal
therapy. The results of these efforts will thus ensure that the Candida
research community has uniform and comprehensive genomic
information for medical research, for the development of functional
genomic tools as well as for future diagnostic and therapeutic
applications.fungi/aspergillus/), and Magnaporthe grisea (Magnaporthe grisea
Database, http://www-genome.wi.mit.edu/annotation/fungi/
magnaporthe/)—as well as to the genomes of ﬁve other
eukaryotes—Arabidopsis thaliana [19], Drosophila melanogaster
[20], Caenorhadbitis elegans [21], Mus musculus [22], and Homo
sapiens [23]—and the GenBank non-redundant (NR) protein
database. Comparisons against the translated C. albicans
genome were also performed to help identify overlapping
genes and putative gene families.
To help interpret such a large number of sequence
comparisons, we organized sequence similarity data in a
Web-accessible database using a novel visualization concept
whereby we used a colorimetric display to indicate BLAST
similarity, which was easy and rapid to scan visually (Figure 1).
The annotators could thus rapidly determine which genes are
potentially unique to C. albicans (e.g., orf19.4741 and
orf19.4786), those that are members of gene families (e.g.,
orf19.4736 and orf19.4779), genes that only have homologs in
fungal genomes (e.g., orf19.4756 and orf19.4778), or those
with homologs in all eukaryotic genomes (e.g., orf19.4732 and
orf19.4784). Finally, a strong hit against the complete NR
database, but not in the other genomes (orf19.4772 and
orf19.4800), allowed us to identify C. albicans genes that had
already been described and submitted to the sequence
databases prior to the publication of assembly orf19. Clicking
on the relevant boxes opened an additional window contain-
ing the precompiled sequence alignments, thus permitting
the validation of interesting observations. These visualization
tools and the results of sequence comparisons are available at
http://candida.bri.nrc.ca/candida/index.cfm?page¼blast.
The coordinates and annotations for all 11,615 putative
ORFs were thus veriﬁed, corrected, and (if necessary)
rewritten by the annotators. We removed ORFs smaller than
300 bp with no signiﬁcant sequence similarity to other genes,
either within the C. albicans genome or in the sequence
databases. In cases where two ORFs overlapped by more than
50%, the smallest gene was removed unless it showed even a
slight sequence similarity to another gene in the sequence
databases. In other cases, we encountered two, or more,
contiguous ORFs that obviously were part of the same gene.
These interruptions were usually due to unidentiﬁed introns
or presumed sequencing errors. In these cases, we decided to
merge the relevant gene fragments into a single entry. A total
of 5,262 ORF entries were thus removed from the database, or
merged with neighboring ORFs, leaving 6,354 conﬁrmed
genes. Sequence and/or annotation data can be obtained in
Dataset S1 or at http://candida.bri.nrc.ca.
A nomenclature for C. albicans genes. Following consulta-
tions with the C. albicans research community during the ﬁfth
and sixth American Society for Microbiology Conferences on
Candida and Candidiasis, it was agreed that C. albicans gene
names should follow the format established for S. cerevisiae
[24]. Gene names consist of three letters (the gene symbol)
followed by an integer (e.g., ADE12); the gene symbol should
be an acronym for, or relate to, the gene function, gene
product, or mutant phenotype. It is preferable that a given
gene symbol have only one meaning, so that all genes using
that symbol are related in some way, for instance, by sharing a
function, participating in a shared pathway, or belonging to
the same gene family. In addition, gene symbols that are used
in S. cerevisiae gene names should retain the same meaning
when used for C. albicans genes. The preﬁx ‘Ca’ has sometimes
been used on gene names to denote that a gene is derived
from C. albicans; however, while the use of preﬁxes adds clarity
to discussions of genes from different species that share a
name (e.g., comparing CaURA3 to ScURA3), the preﬁx is not
considered part of the gene name proper. Finally, allele
designations and deletion symbols should come after the gene
name (ICG1–8 and icg1D for example). For more details on
genetic nomenclature, see the Candida Genome Database
(CGD; [25]) Web page on this topic (http://www.candidagenome.
org/Nomenclature.html).
Wherever possible, genes that are orthologous between C.
albicans and S. cerevisiae should share the same name. We have
provided 3,409 suggested names (in the SuggGene ﬁeld of the
EMBL ﬁles) for many C. albicans ORFs based on their
orthology to S. cerevisiae genes; these are not yet considered
the standard C. albicans gene names, but rather provide
guidance for investigators wishing to name these genes. CGD
assigns standard names to C. albicans genes for which there are
published data (the PubGene ﬁeld). The annotation contains
355 such entries. Generally, CGD considers the ﬁrst published
name in the correct format to be the standard name;
common usage and uniqueness are also considered. All
names that have been used for a gene are collected in CGD,
regardless of their format, so that information from the
literature can be traced to the correct gene. In the current
annotation, additional published gene names have been
placed in the Synonym ﬁeld.
Public access to the data. The complete annotation dataset,
results of BLAST sequence similarity searches, and the
identiﬁcation of conserved protein domains can be obtained
from our Web page (http://candida.bri.nrc.ca/). Furthermore,
CGD (http://www.candidagenome.org), funded by the Na-
tional Institute for Dental and Craniofacial Research of the
National Institutes of Health, will curate the scientiﬁc
literature and provide tools for accessing and analyzing the
C. albicans genome sequence. In addition, CGD will act as a
central repository for gene names and modiﬁcations, as
approved by the C. albicans research community at the
American Society for Microbiology Candida and Candidiasis
meeting in Austin, Texas, in March 2004. CGD itself will not
Figure 1. Visualization of Protein Sequence Similarities
Sample from a Web page used by annotators of the C. albicans genome
to visualize the significance of the best hit from whole-proteome BLASTP
searches. Each putative ORF was compared to the NR database, the
Candida ORF list itself (Ca19; showing results from the four top hits), and
amino acid sequences from the proteomes of S. cerevisiae (Sac), S. pombe
(S.p), M. grisea (Mag), N. crassa (Neu), H. sapiens (H.S), M. musculus (M.m),
D. melanogaster (Dro), C. elegans (C.e), and A. thaliana (A.t). The BLASTP
e-value from the top hit was converted to a color scale as indicated.
Examples of C. albicans genes with interesting similarity patterns are
indicated.
DOI: 10.1371/journal.pgen.0010001.g001
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for the standard gene names and aliases, as the Saccharomyces
Genome Database (SGD) does for the S. cerevisiae community.
CGD hopes that researchers will follow CGD’s gene nomen-
clature guidelines (see above) and keep CGD informed of any
new gene names. Prior to publication, researchers may
reserve a gene name, which will then become the standard
name upon publication. Finally, the CandidaDB database
(http://genolist.pasteur.fr/CandidaDB) [12], which has pro-
vided an annotation of the C. albicans genome sequence since
January 2001, will be updated to take into account the
complete annotation dataset and will continue to provide
tools for accessing and analyzing the C. albicans genome
sequence complementary to those available at the CGD and
the Biotechnology Research Institute.
Content and General Statistics
As detailed in Tables 1 and 2, we identiﬁed 6,354 genes in
version 19 of the C. albicans genome assembly. This number is
certain to change slightly with time as more data come to
light. For instance, 80 of these genes are probably duplicates,
having almost identical counterparts near the extremities of
sequence contigs. Novel genes may also lie in unsequenced/
unassembled gaps between the DNA sequence contigs. We
identiﬁed 246 genes containing mutations or sequencing
errors that result in a frameshift, or the insertion of a stop
codon, that will have to be conﬁrmed through resequencing.
In the meantime, these elements have been joined as a single
ORF entry and tagged with the entry ‘‘sequencing error?’’
inside their Note ﬁeld. We have also identiﬁed 190 genes
truncated at the ends of contigs, only 35 of which have an
identical counterpart on a potentially overlapping contig.
New information will be continuously integrated into the
community data as it is submitted.
The mean protein coding length of 1,439 bp (480 aa) is
almost identical to what has been observed in S. cerevisiae and
S. pombe, while the gene density stands at one gene per 2,342
bp. Short descriptions for all gene products were provided by
annotators, usually based on sequence similarity. A total of
1,218 (19.2%) genes encode unique proteins with no
signiﬁcant homologs in the sequence databases, a percentage
almost identical to that observed in the current version of the
S. cerevisiae annotation [16]. An additional 819 (12.9%) gene
products exhibited signiﬁcant similarities to other proteins of
unknown function. Furthermore, we have provided Enzyme
Commission (EC) numbers and Gene Ontology (GO) terms
for 1,334 and 3,586 gene products, respectively.
Intron analysis. There are 215 ORFs containing at least one
intron, four of which have two introns, one gene (encoding
the Hxt4p transporter) has three, and the SIN3 gene has four.
A total of 43 (20.2%) of these genes encode ribosomal
proteins, 63 (29.6%) encode products with enzymatic activity,
and 26 (12.2%) encode trans-membrane proteins involved in
small molecule transport. We measured the relative position
of introns in their host ORFs and observed that a signiﬁcant
proportion of them are located in the 59 end of ORFs, with
32% of introns being located within the ﬁrst 10% of the
coding sequences. A survey of the distribution of introns in
18 eukaryotic genomes, including S. cerevisiae and H. sapiens,
also indicated a similar bias in intron-poor genomes. It has
been argued that this 59 bias is an indication that introns are
particularly difﬁcult to remove by cDNA recombination,
because of the high activity of these genes and paucity of full-
length cDNA, and that this ﬁnding lends some support to the
idea that introns are being lost more frequently than they are
being gained in these lineages [26], although a more recent
study of four fungal genomes suggests the presence of
additional mechanisms [27].
We surveyed the intron phase distribution and found that
C. albicans has 50.5%, 20.4%, and 29.1% of phase zero, one,
and two introns, respectively. A similar result was observed in
fungal, plant, and animal genomes [27,28], suggesting that a
similar intron phase distribution may be present in ancient
introns and that the intron loss has no preference selection
on intron phases. Seventy out of 215 intron-containing ORFs
have reciprocal best matches with S. cerevisiae genes that also
contain introns. Among these 70 ORFs, 25 introns (35.7%)
share the same position and the same phase. This suggests
that these commonly positioned introns descended from a
common ancestor, as suggested previously [29].
Analysis of protein domains. Table 3 shows the most
abundant protein domains that were identiﬁed in the C.
albicans proteome. As a comparison, we also performed this
analysis on the same ten eukaryotic proteomes that were used
in the BLASTP sequence comparisons. Compared to the S.
Table 1. Features of Completed Fungal Genomes
Species Length (Mb)
Number
of Genes
Mean Coding
Length (bp)
Gene
Density
a
Coding
Percent
Introns
Unique
Proteins
b Reference
C. albicans 14.88 6,354 1,439 2,342 61.5% 224 1,218 (19.2%)
S. cerevisiae 12.16 5,726 1,485 2,124 69.9% 272 1,104 (19.1%) 16
S. pombe 12.46 4,929 1,426 2,528 57.5% 2,034 681 (14%) 17
N. crassa 38.64 10,082 1,673 3,832 43.6% 17,139 4,140 (41%) 18
C. glabrata 12.28 5,283 1,479 2,324 65.0% nd nd 128
Kluyveromyces lactis 10.63 5,329 1,383 1,995 71.6% nd nd 128
Debaryomyces hansenii 12.22 6,906 1,167 1,769 79.2% nd nd 128
Yarrowia lipolytica 20.50 6,703 1,428 3,058 46.3% nd nd 128
Cryptococcus neoformans 19.05 6,572 1,909 2,925 65.8% 34,909 35% 129
aNumber of base pairs in genome divided by number of genes.
bNumber and proportion of proteins with no significant similarity to known proteins.
nd, not determined.
DOI: 10.1371/journal.pgen.0010001.t001
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shows a slight increase in the abundance of leucine-rich
repeats (IPR001611), some zinc ﬁnger transcription factors
(IPR001138), esterases/lipases (IPR000379), and trans-mem-
brane transporters for polyamines (IPR002293) and for
amino acids (IPR004841). If the analysis is expanded to the
other fungal proteomes, only the increased abundance in
leucine-rich repeats appears to be unique to C. albicans.
Genome-Based Identification of Antifungal Targets
One of the main arguments supporting large-scale
sequencing projects for fungal pathogens is the hope of
ﬁnding novel antifungal targets, particularly those that are
absent from the genome of their host. Table 4 shows a list of
228 C. albicans genes that have a very strong sequence
homolog (based on a top hit BLASTP expect value (e-value)
, 1e
 45) in all ﬁve fungal genomes but no signiﬁcant
sequence similarity (best BLASTP e-value . 1e
 10) to genes
in the genomes of either humans or mice. For example, this
list includes FKS1, which encodes a 1,3-beta-glucan synthase
that is the target for the cell wall agents called echinocandins
[30]. The list includes 46 gene products that are assumed to be
located on the plasma membrane, 71 that are predicted to be
involved in the transport of small molecules, and 21 that
appear to be involved, directly or indirectly, with cell wall
synthesis. Furthermore, 41 gene products have been associ-
ated with an EC number, indicating an enzymatic activity,
with phospholipases being the most abundant. The roles and
sites of action of these gene products suggest that they would
be both accessible and theoretically amenable to inhibition
by small molecules.
Short Tandem Repeats
Short tandem repeats (STRs), also called short sequence
repeats or microsatellite DNA, play an important role in
evolution and have been used to characterize population
variability. Although they can arise through DNA polymerase
slippage and unequal recombination, whole-genome analysis
has suggested that additional mechanisms for the control of
STR production/correction remain to be identiﬁed [31–33].
Jones et al. [6] scanned the C. albicans genome for STRs of unit
sizes between two and ﬁve and identiﬁed 1,940 trinucleotide
repeats in their ORF sequences. To conﬁrm that this high
STR frequency is indeed a hallmark of the C. albicans genome,
we used a statistical approach to measure repeat frequencies
in four completed fungal genomes with an emphasis on STRs
that affect protein sequences. We used randomized genome
sequences to calculate the probability that each potential STR
(including mutations that may arise following the ampliﬁca-
tion event) is nonrandom, and used only those with greater
than 95% probability.
As can be seen in Datasets S2–S5 and Table 5, the STR
frequencies in C. albicans and N. crassa are signiﬁcantly greater
than the frequencies observed in S. cerevisiae and S. pombe.
Repeats that occur inside coding sequences are further
characterized in Table 5. As would be expected, repeats with
a modulo of three are more common in coding sequences,
although we note that species with the greatest STR
frequency have the smallest proportion of repeats that would
break a reading frame. While coding sequence STRs in C.
albicans and the other fungi most commonly encode for
repeats of glutamine, asparagine, glutamic acid, and aspartic
acid, we note that some of the repeats that are prevalent in C.
albicans genes are distinct. Repeats of the ACT (threonine)
and TCA (serine) codons are known to be especially rare in
most taxa [31,33]. Correlating STR distribution with Gene
Ontology annotations shows that a signiﬁcant proportion of
the C. albicans genes whose products are classiﬁed as DNA-
binding proteins or cytoskeletal elements also contain STRs.
Several gene products have been shown to play a role in the
generation/correction of novel STRs in eukaryotes [34]. A
comparison of the aa sequences of Rad51p, Rad52p, Mre1p,
Hpr5p, and Pob3p from C. albicans, S. cerevisiae, S. pombe, and N.
crassa did not reveal any signiﬁcant correlation that could be
associated with changes in the STR distribution. The high
proportion of STRs in C. albicans genes argues that this
organism would make a better model than S. cerevisiae for
studying the creation and elongation of these elements that
cause a variety of neuromuscular pathologies in humans. Our
observations further indicate that future studies on STR
frequency in eukaryotic genomes should include a broader
spectrum of fungal genomes. The S. cerevisiae genome has
been used as the fungal representative in comparative studies
published to date [31–33].
Identification of Spurious Genes
Some of the 6,354 predicted ORFs are likely to be spurious.
We used data from S. cerevisiae to model an approach that
combines gene length, gene homology, and gene expression
data to search for spurious gene candidates. Theoretically,
genes with no sequence similarity and with expression
proﬁles that do not correlate with other known genes are
much more likely to be spurious. In an earlier study, spurious
genes in S. cerevisiae were identiﬁed by sequence comparison
between four closely related yeast species [16]. Most did not
have orthologs with other eukaryotes, were of short length,
and had expression proﬁles that were not signiﬁcantly
correlated with those of other genes in the genome (Figure
2A and 2B). Combining both the criteria of sequence
homology and expression correlation produced a list of S.
cerevisiae candidate genes that was highly enriched for ORFs
that were considered to be spurious based on the separate
sequence comparison between the closely related species. We
repeated this homology/expression/length analysis on genes
Table 2. Statistics of the C. albicans Annotation
Parameter Value
Number of genes 6,354
Published/reserved gene names 355
Suggested gene names 3,409
Genes with synonyms/multiple names 85
Genes in putative contig overlaps 80
Truncated genes at end of contigs 190
Sequencing errors/frameshift mutations 246
Gene product descriptions 4,317
Conserved hypothetical proteins 819
Hypothetical proteins 1,218
Products with EC numbers 1,334
Total number of EC numbers 1,463
Products with GO Terms
a 3,438
Number of GO terms
a 13,835
aExcluding ‘‘unknown.’’
DOI: 10.1371/journal.pgen.0010001.t002
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Annotation of the Candida albicans GenomeTable 3. Number, Abundance Ranking, and Proportion of Gene Products Containing the Indicated Interpro Protein Domain in C.
albicans and Other Eukaryotes
Interpro Description C. alb-
icans
S. cer-
evisiae
S.
pombe
A.
niger
M.
grisea
N.
crassa
A.
thaliana
C.
elegans
D. mela-
nogaster
M.
musculus
H.
sapiens
IPR011009 Protein kinase-like
124 (1)
1.95%
136 (1)
2.19%
129 (2)
2.59%
140 (4)
1.47%
146 (3)
1.31%
142 (1)
1.41%
1,146 (1)
3.98%
1,015 (2)
3.05%
472 (1)
2.64%
592 (6)
2.33%
700 (4)
2.76%
IPR008938 ARM repeat fold
112 (2)
1.76%
109 (6)
1.76%
131 (1)
2.63%
116 (12)
1.22%
108 (11)
0.97%
120 (5)
1.19%
390 (12)
1.35%
384 (16)
1.15%
270 (7)
1.51%
364 (11)
1.43%
388 (13)
1.53%
IPR011046 WD40-like
111 (3)
1.74%
120 (3)
1.93%
121 (3)
2.43%
125 (9)
1.31%
105 (12)
0.95%
120 (4)
1.19%
267 (23)
0.93%
310 (18)
0.93%
245 (11)
1.37%
278 (22)
1.10%
326 (20)
1.29%
IPR000719 Protein kinase
105 (4)
1.65%
123 (2)
1.98%
109 (5)
2.19%
117 (11)
1.23%
117 (7)
1.05%
126 (2)
1.25%
1,122 (2)
3.90%
908 (3)
2.73%
401 (3)
2.24%
572 (7)
2.25%
678 (5)
2.68%
IPR001680
G protein beta
WD40 repeat
100 (5)
1.57%
101 (8)
1.63%
119 (4)
2.39%
126 (8)
1.32%
114 (9)
1.03%
121 (3)
1.20%
297 (18)
1.03%
283 (22)
0.85%
238 (12)
1.33%
286 (19)
1.13%
333 (19)
1.32%
IPR002290
Serine/threonine
protein kinase
96 (6)
1.51%
114 (4)
1.84%
105 (6)
2.11%
102 (17)
1.07%
99 (14)
0.89%
99 (7)
0.98%
1,068 (3)
3.71%
829 (4)
2.49%
359 (4)
2.01%
509 (8)
2.01%
635 (6)
2.51%
IPR008271
Serine/threonine
protein kinase,
active site
92 (7)
1.44%
111 (5)
1.79%
94 (8)
1.89%
86 (19)
0.90%
78 (27)
0.70%
80 (13)
0.79%
848 (5)
2.95%
453 (12)
1.36%
253 (9)
1.42%
322 (14)
1.27%
415 (10)
1.64%
IPR001138
Fungal transcriptional
regulatory protein,
N-terminal
76 (9)
1.19%
53 (16)
0.85%
31 (24)
0.62%
217 (2)
2.27%
122 (6)
1.10%
93 (9)
0.92%
1 (3125)
0%
—— —
1 (3209)
0%
IPR003593 AAA ATPase
75 (10)
1.18%
82 (9)
1.32%
69 (11)
1.39%
107 (15)
1.12%
92 (16)
0.83%
93 (10)
0.92%
322 (16)
1.12%
185 (41)
0.56%
160 (24)
0.89%
136 (52)
0.54%
172 (43)
0.68%
IPR007114
Major facilitator
superfamily
71 (11)
1.11%
62 (14)
1%
52 (14)
1.05%
293 (1)
3.07%
175 (1)
1.58%
115 (6)
1.14%
107 (66)
0.37%
211 (34)
0.63%
139 (30)
0.78%
88 (88)
0.35%
97 (85)
0.38%
IPR008941 TPR-like
71 (12)
1.11%
63 (13)
1.02%
70 (10)
1.41%
112 (13)
1.17%
86 (19)
0.77%
82 (12)
0.81%
623 (7)
2.16%
218 (32)
0.65%
184 (18)
1.03%
225 (30)
0.89%
245 (31)
0.97%
IPR001410
DEAD/DEAH
box helicase
65 (13)
1.02%
78 (10)
1.26%
68 (12)
1.37%
71 (29)
0.74%
71 (33)
0.64%
74 (16)
0.73%
156 (41)
0.54%
178 (43)
0.53%
99 (49)
0.55%
117 (66)
0.46%
126 (63)
0.50%
IPR001650
Helicase,
C-terminal
63 (14)
0.99%
76 (11)
1.23%
67 (13)
1.35%
70 (30)
0.73%
73 (31)
0.66%
70 (18)
0.69%
153 (43)
0.53%
165 (52)
0.50%
101 (44)
0.56%
110 (68)
0.43%
120 (68)
0.47%
IPR001611 Leucine-rich repeat
62 (15)
0.97%
14 (98)
0.23%
13 (95)
0.26%
16 (142)
0.17%
14 (157)
0.13%
16 (104)
0.16%
556 (8)
1.93%
158 (55)
0.47%
174 (19)
0.97%
261 (24)
1.03%
288 (25)
1.14%
IPR000504
RNA-binding
region RNP-1
(RNA recognition motif)
60 (16)
0.94%
65 (12)
1.05%
86 (9)
1.73%
81 (24)
0.85%
81 (24)
0.73%
76 (15)
0.75%
346 (14)
1.20%
266 (23)
0.80%
296 (6)
1.66%
305 (17)
1.20%
333 (18)
1.32%
IPR000379
Esterase/lipase/
thioesterase
54 (17)
0.85%
37 (22)
0.60%
26 (33)
0.52%
103 (16)
1.08%
115 (8)
1.04%
76 (14)
0.75%
237 (25)
0.82%
223 (28)
0.67%
165 (22)
0.92%
118 (65)
0.47%
112 (73)
0.44%
IPR007087 Zinc finger, C2H2 type
53 (18)
0.83%
53 (15)
0.85%
34 (20)
0.68%
84 (20)
0.88%
99 (13)
0.89%
97 (8)
0.96%
190 (29)
0.66%
389 (15)
1.17%
433 (2)
2.42%
712 (4)
2.81%
879 (1)
3.47%
IPR000345
Cytochrome c
heme-binding site
43 (19)
0.68%
39 (21)
0.63%
37 (17)
0.74%
61 (35)
0.64%
80 (25)
0.72%
51 (26)
0.51%
281 (19)
0.98%
238 (27)
0.71%
202 (16)
1.13%
262 (23)
1.03%
303 (24)
1.20%
IPR001841 Zinc finger, RING
41 (20)
0.64%
35 (26)
0.56%
46 (16)
0.92%
38 (54)
0.40%
48 (41)
0.43%
52 (23)
0.52%
489 (10)
1.70%
261 (24)
0.78%
159 (25)
0.89%
293 (18)
1.15%
339 (17)
1.34%
IPR009057 Homeodomain-like
40 (21)
0.63%
33 (31)
0.53%
27 (31)
0.54%
67 (31)
0.70%
128 (5)
1.15%
42 (31)
0.42%
490 (9)
1.70%
404 (14)
1.21%
210 (15)
1.17%
362 (12)
1.43%
397 (11)
1.57%
IPR005828
General substrate
transporter
38 (22)
0.60%
39 (20)
0.63%
29 (27)
0.58%
128 (7)
1.34%
75 (30)
0.68%
52 (24)
0.52%
88 (87)
0.31%
101 (85)
0.30%
95 (51)
0.53%
38 (230)
0.15%
45 (202)
0.18%
IPR008994
Nucleic-acid-binding
OB-fold
38 (23)
0.60%
41 (18)
0.66%
51 (15)
1.02%
44 (50)
0.46%
45 (43)
0.41%
45 (30)
0.45%
268 (22)
0.93%
92 (91)
0.28%
70 (61)
0.39%
112 (67)
0.44%
94 (86)
0.37%
IPR002048
Calcium-binding
EF-hand
38 (24)
0.60%
26 (45)
0.42%
33 (21)
0.66%
41 (51)
0.43%
37 (57)
0.33%
46 (28)
0.46%
269 (2%1)
0.93
219 (31)
0.66%
172 (20)
0.96%
286 (20)
1.13%
321 (21)
1.27%
IPR002293
Amino acid/polyamine
transporter I
37 (25)
0.58%
25 (49)
0.40%
21 (47)
0.42%
58 (36)
0.61%
26 (85)
0.23%
18 (90)
0.18%
18 (459)
0.06%
32 (283)
0.10%
27 (211)
0.15%
26 (337)
0.10%
23 (411)
0.09%
IPR005225
Small GTP-binding
protein domain
37 (26)
0.58%
43 (17)
0.69%
35 (19)
0.70%
35 (61)
0.37%
38 (54)
0.34%
38 (36)
0.38%
128 (53)
0.44%
118 (72)
0.35%
117 (34)
0.65%
163 (39)
0.64%
180 (39)
0.71%
IPR005829
Sugar transporter
superfamily
35 (27)
0.55%
40 (19)
0.64%
23 (40)
0.46%
107 (14)
1.12%
61 (34)
0.55%
47 (27)
0.47%
109 (64)
0.38%
70 (130)
0.21%
76 (60)
0.43%
49 (168)
0.19%
58 (142)
0.23%
IPR004841
Amino acid permease-
associated region
34 (28)
0.53%
24 (52)
0.39%
21 (48)
0.42%
48 (47)
0.50%
25 (89)
0.23%
18 (91)
0.18%
18 (470)
0.06%
30 (295)
0.09%
27 (203)
0.15%
25 (367)
0.10%
22 (418)
0.09%
IPR001440 TPR repeat
34 (29)
0.53%
33 (29)
0.53%
37 (18)
0.74%
53 (43)
0.56%
42 (47)
0.38%
38 (35)
0.38%
152 (44)
0.53%
125 (69)
0.38%
108 (36)
0.60%
151 (46)
0.60%
160 (47)
0.63%
IPR001993
Mitochondrial
substrate carrier
33 (30)
0.52%
34 (28)
0.55%
23 (38)
0.46%
36 (60)
0.38%
36 (60)
0.32%
35 (40)
0.35%
61 (140)
0.21%
59 (160)
0.18%
69 (63)
0.39%
58 (135)
0.23%
61 (137)
0.24%
Numbers represent how many gene products have the given domain. Ordered ranking of each domain is given in parentheses. Percentages represent the proportion of gene products that contain at least one of the domains.
DOI: 10.1371/journal.pgen.0010001.t003
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Annotation of the Candida albicans GenomeTable 4. Genes from C. albicans with a Strong Homolog in the S. cerevisiae, S. pombe, A. niger, M. grisea, and N. crassa genomes but
Absent from the H. sapiens and M. musculus Genomes
Systematic ID Name Product
orf19.2929 GSL2 1,3-Beta-D-glucan synthase subunit
orf19.2495 FKS1 1,3-Beta-glucan synthase; target for echinocandin antifungal drugs
orf19.1517 2-Dehydro-3-deoxy-phosphoheptonate aldolase
orf19.6086 LEU4 2-Isopropylmalalate synthase
orf19.3106 MET16 39-Phosphoadenylylsulfate reductase
orf19.99 MET222 39(29)59-Bisphosphate nucleotidase, possibly involved in salt tolerance and methionine synthesis
orf19.4060 ARO4 3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase isoenzyme
orf19.2269 3-Phosphoserine phosphatase
orf19.5113 ADH2 Alcohol dehydrogenase
orf19.309 DAL5 Allantoate permease
orf19.3208 DAL6 Allantoate permease
orf19.5023 DAL7 Allantoate permease
orf19.5859 DAL8 Allantoate permease
orf19.6522 Allantoate permease
orf19.6956 DAL9 Allantoate permease
orf19.313 DAL4 Allantoin permease
orf19.1663 KRE2 Alpha-1,2-mannosyltransferase
orf19.1665 KTR1 Alpha-1,2-mannosyltransferase involved in N- and O-linked glycosylation
orf19.1375 LEU6 Alpha-isopropylmalate synthase
orf19.2810 AAP1 Amino acid permease
orf19.3795 AGP3 Amino acid permease
orf19.4679 AGP2 Amino acid permease
orf19.5672 MEP2 Ammonia permease
orf19.7428 APN1 Apurinic/apyrimidinic endonuclease/39-repair diesterase
orf19.111 CAN1 Arginine permease
orf19.97 CAN2 Arginine permease
orf19.1235 HOM3 Aspartate kinase (L-aspartate 4-P-transferase)
orf19.6959 HOM32 Aspartate kinase (L-aspartate 4-P-transferase); L-aspartate 4-P-transferase
orf19.1559 HOM2 Aspartate-semialdehyde dehydrogenase; threonine and methionine pathway
orf19.4026 HIS1 ATP phosphoribosyltransferase
orf19.5970 HPR5 ATP-dependent DNA helicase involved in DNA repair
orf19.7213 ATP-dependent RNA helicase
orf19.5604 MDR1 Benomyl/methotrexate resistance protein
orf19.7670 Ca
2þ/H
þ antiporter conserved in fungi
orf19.5796 SHE9 Causes growth arrest when overexpressed
orf19.5531 CDC37 Cell division control protein
orf19.807 CHS5 Chitin biosynthesis protein
orf19.5188 CHS1 Chitin synthase
orf19.7298 CHS2 Chitin synthase 2
orf19.5384 CHS8 Chitin synthase 8
orf19.2946 HNM4 Choline permease
orf19.1170 Chorismate mutase
orf19.1986 ARO2 Chorismate synthase
orf19.3489 ARO22 Chorismate synthase
orf19.5932 Conserved hypothetical membrane protein
orf19.1240 Conserved hypothetical protein
orf19.246 Conserved hypothetical protein
orf19.2703 Conserved hypothetical protein
orf19.3288 Conserved hypothetical protein
orf19.4907 Conserved hypothetical protein
orf19.5342 Conserved hypothetical protein
orf19.5541 Conserved hypothetical protein
orf19.5605 Conserved hypothetical protein
orf19.5667 MNR2 Conserved hypothetical protein; putative ion transporter
orf19.1427 Conserved hypothetical transporter
orf19.988 Conserved membrane protein
orf19.778 PIL1 Conserved protein
orf19.1989 DCW1 Defective cell wall
orf19.2445 DIP5 Dicarboxylic amino acid permease
orf19.579 FOL1 Dihydroneopterin aldolase, dihydro-6-hydroxymethylpterin pyrophosphokinase
orf19.4040 ILV3 Dihydroxyacid dehydratase
orf19.843 DNA repair exonuclease
orf19.3417 ACF2 Endo-1,3-beta-glucanase; involved in actin polymerization
orf19.3066 ACF3 Endo-1,3-beta-glucanase
orf19.979 FAS1 Fatty-acyl-CoA synthase, beta chain
orf19.3203 RCY1 F-box protein: endocytic membrane traffic, recycling
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Annotation of the Candida albicans GenomeTable 4. Continued
Systematic ID Name Product
orf19.2075 DFG5 Filamentous growth, cell polarity, and elongation
orf19.5285 PST3 Flavodoxin
orf19.5286 YCP4 Flavodoxin
orf19.4618 FBA1 Fructose-bisphosphate aldolase
orf19.6882 OSM1 Fumarate reductase flavoprotein subunit
orf19.5658 MNN10 Mannosyltransferase
orf19.1232 VRG4 GDP-mannose transporter into the lumen of the Golgi
orf19.1799 GAP6 General amino acid permease
orf19.3195 GAP3 General amino acid permease
orf19.4304 GAP1 General amino acid permease
orf19.6659 GAP5 General amino acid permease
orf19.2990 XOG1 Glucan 1,3-beta-glucosidase
orf19.1719 SGA1 Glucoamylase
orf19.5815 SCT2 Glycerol-3-phosphate acyltransferase
orf19.1289 SCT1 Glycerol-3-phosphate O-acyltransferase
orf19.1978 GIT2 Glycerophosphoinositol permease
orf19.1979 GIT3 Glycerophosphoinositol permease
orf19.1980 GIT4 Glycerophosphoinositol permease
orf19.377 PHR3 Glycophospholipid
orf19.4035 GAS1 Glycosylphosphatidylinositol anchored surface protein
orf19.2862 RIB1 GTP cyclohydrolase II, first step in riboflavin biosynthesis
orf19.2626 RGD2 GTPase activating protein
orf19.730 RGD3 GTPase activating protein (GAP) for Rho
orf19.1422 FZO1 GTPase required for biogenesis of mitochondria
orf19.6387 HSP104 Heat shock protein 104
orf19.1193 GNP2 High-affinity glutamine permease
orf19.7565 GNP3 High-affinity glutamine permease
orf19.7566 GNP1 High-affinity glutamine permease
orf19.2337 ALP1 High-affinity permease for basic amino acids
orf19.3222 Highly conserved hypothetical protein
orf19.3395 Highly conserved hypothetical protein
orf19.2350 Highly conserved hypothetical protein, MFS family transporter
orf19.4940 HIP1 Histidine permease
orf19.5639 HIS4 Histidinol dehydrogenase
orf19.4506 LYS22 Homocitrate synthase
orf19.772 LYS21 Homocitrate synthase
orf19.923 THR1 Homoserine kinase
orf19.2618 MET2 Homoserine O-acetyltransferase
orf19.2987 Hypothetical membrane protein
orf19.5505 HIS7 Imidazole glycerol phosphate synthase; histidine biosynthesis
orf19.183 HIS3 Imidazoleglycerol-phosphate dehydratase
orf19.3355 ISN1 Inosine 59-monophosphate 59-nucleotidase
orf19.4379 PRP13 Integral membrane mitochondrial protein
orf19.1112 BUD7 Involved in bud-site selection
orf19.6068 SVF1 Involved in diauxic shift
orf19.5986 THI4 Involved in thiamine biosynthesis pathway and DNA repair
orf19.2179 ARN1 Iron-siderophore transporter
orf19.6844 ICL1 Isocitrate lyase
orf19.3412 ATG15 Lipase involved in autophagy
orf19.5839 PDR17 Lipid biosynthesis and multidrug resistance
orf19.3149 LSP1 Long-chain base; stimulates phosphorylation
orf19.1614 MEP1 Low-affinity high-capacity ammonium permease
orf19.600 TRK1 Low-affinity potassium transporter
orf19.3663 PHO91 Low-affinity phosphate transporter
orf19.3622 ANP1 Mannan 8; Golgi mannosyltransferase required for protein glycosylation
orf19.3171 ACH1 Mannose-containing glycoprotein that binds concanavalin A; acetyl-CoA hydrolase
orf19.4494 KTR2 Mannosyltransferase
orf19.1010 KTR3 Mannosyltransferase involved in O- and N-linked glycosylation
orf19.7158 Member of allantoate permease family
orf19.2160 NAG4 Membrane transporter
orf19.2170 Membrane transporter
orf19.4805 RSN1 Membrane transporter
orf19.4737 DHA12 Membrane transporter of the MFS-MDR family
orf19.7391 OCH1 Membrane-bound alpha-1,6-mannosyltransferase
orf19.5811 MET1 Methionine metabolism; siroheme synthase; uroporphyrin-3 C-methyltransferase
orf19.2551 MET6 Methionine-synthesizing 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase
orf19.339 NDE1 Mitochondria-directed NADH dehydrogenase
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Annotation of the Candida albicans GenomeTable 4. Continued
Systematic ID Name Product
orf19.2956 MGM101 Mitochondrial genome maintenance protein
orf19.4351 PRP12 Mitochondrial inner membrane protein
orf19.88 ILV5 Mitochondrial ketol-acid reductoisomerase
orf19.2597 MRS2 Mitochondrial magnesium ion transporter, essential for splicing of group II introns
orf19.3422 FMP27 Mitochondrial protein
orf19.2115 Molybdopterin-converting factor
orf19.943 FET33 Multicopper ferro-O2-oxidoreductase
orf19.6577 TPO1 Multidrug resistance protein
orf19.7148 TPO2 Multidrug resistance proteins; polyamine transport protein
orf19.4779 Multidrug resistance transporter
orf19.304 Multidrug-resistance-type transporter
orf19.367 CNH1 Na
þ/H
þ antiporter
orf19.5713 NDE1 NADH dehydrogenase
orf19.125 EBP1 NADH: flavin oxidoreductase (old yellow enzyme)
orf19.3612 PST2 NADH: quinone oxidoreductase; 1,4-benzoquinone reductase
orf19.2192 GDH2 NAD-specific glutamate dehydrogenase
orf19.3443 OYE2 NAPDH dehydrogenase (old yellow enzyme)
orf19.3433 OYE23 NAPDH dehydrogenase (old yellow enzyme), isoform 2
orf19.7176 NPT1 Nnicotinate phosphoribosyltransferase
orf19.2055 NPL6 Nuclear protein localization factor
orf19.176 Oligopeptide transporter
orf19.2292 OPT4 Oligopeptide transporter protein
orf19.3746 OPT2 Oligopeptide transporter protein
orf19.3749 OPT3 Oligopeptide transporter protein
orf19.4655 OPT6 Oligopeptide transporter protein
orf19.5121 OPT5 Oligopeptide transporter protein
orf19.5673 OPT7 Oligopeptide transporter protein
orf19.2602 OPT1 Oligopeptide transporter specific for tetra- and pentapeptides
orf19.6500 ECM40 Ornithine acetyltransferase
orf19.1291 ABZ1 Para-aminobenzoate synthase (PABA)
orf19.4704 ARO1 Pentafunctional arom polypeptide
orf19.3718 Peptide transporter
orf19.34 GIT1 Permease involved in the uptake of glycerophosphoinositol (GroPIns)
orf19.6081 PHR2 pH-regulated cell wall protein
orf19.3829 PHR1 pH-regulated GPI-anchored membrane protein that is required for morphogenesis
orf19.169 CHO2 Phosphatidyl-ethanolamine N-methyltransferase
orf19.1027 PDR16 Phosphatidylinositol transfer protein; drug resistance
orf19.677 CHO1 Phosphatidylserine synthase
orf19.5102 PLB5 Phospholipase B/lysophospholipase
orf19.6594 PLB4 Phospholipase B/lysophospholipase
orf19.689 PLB1 Phospholipase B/lysophospholipase
orf19.690 PLB2 Phospholipase B/lysophospholipase
orf19.7484 ADE1 Phosphoribosyl-amidoimidazole-succinocarboxamide synthetase
orf19.5906 ADE2 Phosphoribosylamino-imidazole-carboxylase; purine biosynthesis
orf19.4381 VTC2 Polyphosphate synthetase
orf19.3363 VTC4 Polyphosphate synthetase
orf19.1504 Potential patatin-like phospholipase
orf19.5426 Predicted esterase of the alpha-beta hydrolase superfamily
orf19.4605 TYR1 Prephenate dehydrogenase; tyrosine biosynthesis
orf19.2945 PUT4 Proline permease
orf19.7577 MSS51 Protein involved in maturation of COX1 and COB mRNA
orf19.6520 Putative allantoate permease
orf19.5995 MCA1 Putative cysteine protease
orf19.1607 ALR1 Putative divalent cation transporter
orf19.2798 Putative helicase
orf19.4475 MNT4 Putative mannosyltransferase
orf19.5029 MODF Putative membrane protein
orf19.685 YHM1 Putative mitochondrial carrier protein
orf19.4446 Putative permease
orf19.5031 SSK1 Putative reponse regulator two-component phosphorelay gene
orf19.2151 SEY1 Putative stress-related vesicular transport protein
orf19.3232 Putative transporter
orf19.4608 PDC12 Pyruvate decarboxylase I
orf19.4650 ILV6 Regulatory subunit of acetolacetate synthase
orf19.1311 SPO75 Related to yeast sporulation protein
orf19.7383 MNN9 Required for complex glycosylation
orf19.4024 RIB5 Riboflavin synthase
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Annotation of the Candida albicans Genomeof the C. albicans genome. C. albicans genes with an ortholog in
other eukaryotes are assumed to be real and were excluded as
candidates (510 of 513 S. cerevisiae genes ruled spurious by the
reading frame conservation test [16] had no ortholog in C.
albicans). In the above analysis, approximately 1,000 gene
expression experiments were analyzed for S. cerevisiae [35],
while approximately 200 currently available experiments
were analyzed for C. albicans (see Materials and Methods).
Table S1 includes a ranked list of the 349 C. albicans genes that
are the most likely to be spurious.
Table 4. Continued
Systematic ID Name Product
orf19.6727 RIT1 Ribosyltransferase of initiator tRNA methionine
orf19.5071 NRP1 RNA-binding Ran zinc finger protein
orf19.1789.1 LYS1 Saccharopine dehydrogenase
orf19.1631 ERG6 S-adenosyl-methionine delta-24-sterol-C-methyltransferase
orf19.1474 SLA1 SH3 domain protein involved in assembly of cortical actin cytoskeleton
orf19.3693 GAS12 Similar to GPI-anchored surface protein GAS1
orf19.4151 SPO1 Similar to phospholipase B
orf19.473 TPO4 Sperimidine transporter
orf19.341 TPO3 Spermidine exporter, MDR-type pump
orf19.5827 BUB2 Spindle body component required for cell cycle arrest in response to loss of microtubule function
orf19.2947 SNZ1 Stationary phase protein
orf19.1203 SRO77 Suppressor of defect in the small GTPase Rho3p
orf19.277 THI6 Thiamin-phosphate pyrophosphorylase and hydroxyethylthiazole kinase
orf19.889 THI20 Thiamine biosynthesis; phosphomethylpyrimidine kinase
orf19.4290 TRR1 Thioredoxin reductase
orf19.3038 TPS2 Threalose-6-phosphate phosphatase
orf19.814 SSY1.5 Transcriptional regulator of multiple amino acid permeases
orf19.4335 TNA1 Transporter of nicotinic acid
orf19.6640 TPS1 Trehalose-6-phosphate synthase
orf19.6511 TRL1 tRNA ligase
orf19.7205 DUR7 Urea active transport protein
orf19.781 DUR3 Urea active transport protein
orf19.5677 DUR4 Urea permease
orf19.405 VCX1 Vacuolar H
þ/Ca
2þ exchanger
orf19.3344 VPS17 Vacuolar sorting protein
orf19.6324 VID27 Vacuole import and degradation
orf19.6738 VAN1 Vanadate resistance protein
orf19.4621 Weak similarity to pig tubulin-tyrosine ligase
DOI: 10.1371/journal.pgen.0010001.t004
Figure 2. Identification of Spurious Genes
Assessing criteria that identify candidate spurious genes in S. cerevisiae, using a reference set of known spurious genes [16].
(A) For every gene in S. cerevisiae, the average Pearson correlation coefficient with all other genes was calculated. Shown are histograms of the
correlations associated with genes characterized as spurious in the reading frame conservation test ([16]; red) and all genes in the genome (black).
(B) The distribution of gene lengths is shown for genes characterized as spurious (red) and for all genes of the genome (black).
(C) Assessing the likelihood of being spurious as a function of gene length and correlation score. Shown is the proportion of spurious genes out of all
genes whose length and correlation score fall into each of the intervals. The proportion is color-coded according to the color bar shown. S. cerevisiae
genes with an ortholog in C. albicans were excluded from the analysis.
DOI: 10.1371/journal.pgen.0010001.g002
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Many putative and demonstrated virulence factors of C.
albicans are members of large multigene families. Well-known
examples of such families encode secreted aspartyl protein-
ases [36,37]), agglutinins [38], secreted lipases [39], high-
Table 5. Frequency and Characteristics of Short Tandem Repeats
in the Coding Sequences of Fungal Genomes
Characteristic S. pombe S. cerevisiae C. albicans N. crassa
Number of STR95s
a
in coding sequence 225 922 2,640 4,721
Number of genes 4,984 5,888 6,354 10,082
Percent of genes
with one or more
STR95s 4.5% 15.7% 41.5% 46.8%
Number of STR
of the indicated
periodicity in coding
sequences
1 32 179 457 514
22 8 1 8 1 5
3 64 445 3,697 6,876
46 3 3 5 7 4
57 1 2 7 3 1
6 78 304 1,316 2,140
72 3 8 1 6
85 1 7 2 3
9 52 163 469 924
10 0 8 6 17
11 0 7 1 14
12 6 127 288 376
13 0 0 2 4
14 0 0 2 0
15 0 44 45 122
16 0 0 0 1
17 0 0 0 0
18 0 14 47 51
19 0 0 0 0
20 0 0 0 0
Proportion of
Modulo3 repeats 78.7% 83.9% 91.4% 93.7%
Distribution of
encoded amino
acids sequences
in trinucleotide
repeats (rank,
amino acid, number) 5 A 122 6 A 562 9 A 1,942 4 A 8,198
C — 19 C 17 19 C 68 19 C 103
4 D 153 4 D 1,334 5 D 4,599 6 D 6,141
1E 276 3 E 1,351 3 E 5,553 2 E 8,824
16 F 10 18 F 21 17 F 225 17 F 445
9G 77 10 G 250 8 G 2,493 3 G 8,205
12H 20 11 H 208 11 H 1,109 12 H 1,900
15 I 15 15 I 71 14 I 589 15 I 626
3 K 158 7 K 472 10 K 1,837 9 K 4,282
13 L 18 14 L 87 12 L 771 14 L 1,395
14M 16 17 M 53 18 M 181 16 M 523
8 N 88 2 N 1,369 2 N 6,448 10 N 3,717
6 P 109 9 P 304 7 P 2,504 7 P 5,085
7 Q 97 1 Q 1,942 1 Q 7,805 1 Q 9,389
11 R 34 12 R 113 15 R 486 11 R 2,155
2 S 207 5 S 1,099 4 S 4,706 5 S 7,881
10 T 43 8 T 394 6 T 4,518 8 T 5,072
12 V 20 13 V 89 13 V 615 13 V 1,539
W — W— 2 0 W3 32 0 W8 2
17 Y 8 16 Y 60 16 Y 399 18 Y 384
Codon (and encoded
amino acid) frequency
in trinucleotide
repeats .13 bp
(number [percentage])
AAA (K) 2 (1.0) 6 (1.0) 21 (0.7) 3 (0.1)
AAC (N) 2 (1.0) 39 (6.5) 242 (7.8) 194 (5.5)
AAG (K) 12 (6.1) 23 (3.9) 30 (1.0) 136 (3.8)
AAT (N) 6 (3.0) 81 (13.6) 252 (8.1) 4 (0.1)
ACA (T) 2 (1.0) 0 (0.0) 132 (4.3) 61 (1.7)
ACC (T) 0 (0.0) 0 (0.0) 98 (3.2) 159 (4.5)
Table 5. Continued
Characteristic S. pombe S. cerevisiae C. albicans N. crassa
ACG (T) 0 (0.0) 0 (0.0) 1 (0.0) 38 (1.1)
ACT (T) 4 (2.0) 5 (0.8) 137 (4.4) 19 (0.5)
AGA (R) 1 (0.5) 7 (1.2) 15 (0.5) 6 (0.2)
AGC (S) 1 (0.5) 5 (0.8) 6 (0.2) 86 (2.4)
AGG (R) 0 (0.0) 1 (0.2) 2 (0.1) 20 (0.6)
AGT (S) 1 (0.5) 1 (0.2) 37 (1.2) 14 (0.4)
ATA (I) 0 (0.0) 2 (0.3) 5 (0.2) 1 (0.0)
ATC (I) 0 (0.0) 1 (0.2) 3 (0.1) 8 (0.2)
ATG (M) 0 (0.0) 1 (0.2) 14 (0.5) 8 (0.2)
ATT (I) 1 (0.5) 1 (0.2) 6 (0.2) 0 (0.0)
CAA (Q) 7 (3.6) 71 (11.9) 623 (20.1) 270 (7.6)
CAC (H) 0 (0.0) 2 (0.3) 22 (0.7) 51 (1.4)
CAG (Q) 1 (0.5) 48 (8.1) 54 (1.7) 326 (9.2)
CAT (H) 3 (1.5) 4 (0.7) 37 (1.2) 21 (0.6)
CCA (P) 5 (2.5) 7 (1.2) 109 (3.5) 89 (2.5)
CCC (P) 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0)
CCG (P) 0 (0.0) 0 (0.0) 0 (0.0) 68 (1.9)
CCT (P) 11 (5.6) 8 (1.3) 14 (0.5) 79 (2.2)
CGA (R) 0 (0.0) 0 (0.0) 3 (0.1) 3 (0.1)
CGC (R) 0 (0.0) 0 (0.0) 0 (0.0) 8 (0.2)
CGG (R) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.1)
CGT (R) 3 (1.5) 0 (0.0) 2 (0.1) 4 (0.1)
CTA (L) 0 (0.0) 0 (0.0) 5 (0.2) 1 (0.0)
CTC (L) 0 (0.0) 0 (0.0) 0 (0.0) 21 (0.6)
CTG (L/S) 0 (0.0) 0 (0.0) 7 (0.2) 13 (0.4)
CTT (L) 0 (0.0) 0 (0.0) 4 (0.1) 0 (0.0)
GAA (E) 48 (24.4) 97 (16.3) 371 (12.0) 125 (3.5)
GAC (D) 1 (0.5) 18 (3.0) 30 (1.0) 113 (3.2)
GAG (E) 4 (2.0) 8 (1.3) 29 (0.9) 257 (7.2)
GAT (D) 25 (12.7) 67 (11.2) 235 (7.6) 103 (2.9)
GCA (A) 4 (2.0) 7 (1.2) 25 (0.8) 62 (1.7)
GCC (A) 0 (0.0) 0 (0.0) 4 (0.1) 119 (3.4)
GCG (A) 0 (0.0) 0 (0.0) 1 (0.0) 57 (1.6)
GCT (A) 19 (9.6) 14 (2.3) 70 (2.3) 167 (4.7)
GGA (G) 0 (0.0) 0 (0.0) 18 (0.6) 131 (3.7)
GGC (G) 0 (0.0) 0 (0.0) 1 (0.0) 110 (3.1)
GGG (G) 0 (0.0) 0 (0.0) 2 (0.1) 2 (0.1)
GGT (G) 3 (1.5) 14 (2.3) 124 (4.0) 196 (5.5)
GTA (V) 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0)
GTC (V) 0 (0.0) 0 (0.0) 0 (0.0) 7 (0.2)
GTG (V) 0 (0.0) 0 (0.0) 5 (0.2) 17 (0.5)
GTT (V) 1 (0.5) 5 (0.8) 13 (0.4) 4 (0.1)
TAA (*) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
TAC (Y) 0 (0.0) 1 (0.2) 3 (0.1) 1 (0.0)
TAG (*) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0)
TAT (Y) 2 (1.0) 0 (0.0) 7 (0.2) 0 (0.0)
TCA (S) 1 (0.5) 12 (2.0) 122 (3.9) 56 (1.6)
TCC (S) 4 (2.0) 8 (1.3) 10 (0.3) 152 (4.3)
TCG (S) 2 (1.0) 2 (0.3) 8 (0.3) 27 (0.8)
TCT (S) 16 (8.1) 19 (3.2) 77 (2.5) 110 (3.1)
TGA (*) 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0)
TGC (C) 0 (0.0) 0 (0.0) 2 (0.1) 0 (0.0)
TGG (C) 0 (0.0) 0 (0.0) 4 (0.1) 3 (0.1)
TGT (C) 1 (0.5) 1 (0.2) 0 (0.0) 0 (0.0)
TTA (L) 0 (0.0) 5 (0.8) 16 (0.5) 0 (0.0)
TTC (F) 0 (0.0) 1 (0.2) 3 (0.1) 4 (0.1)
TTG (L) 0 (0.0) 0 (0.0) 9 (0.3) 6 (0.2)
TTT (F) 4 (2.0) 4 (0.7) 26 (0.8) 5 (0.1)
aSTRs with a less than 5% chance of being random
DOI: 10.1371/journal.pgen.0010001.t005
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Annotation of the Candida albicans Genomeafﬁnity iron transporters [40], and ferric reductases [41].
Members of each of these families are differentially expressed
as a function of the yeast–hyphae transition, phenotypic
switching, or timing during experimental infection. Also,
each of these families is large relative to the corresponding
homolog or family of homologs in S. cerevisiae, leading to the
concept that expansion of many C. albicans gene families may
be an adaptation to a commensal lifestyle and may be, in part,
responsible for C. albicans’s unusual ability to occupy a variety
of host niches.
The sequencing of the genome provides an opportunity to
survey the global occurrence and extent of multigene families
as a ﬁrst step in assessing their contribution to colonization
and disease. We devised a purely computational method to
deﬁne a comprehensive list of multigene families using NCBI-
BLAST and custom Perl scripts. Each translated ORF in the
annotated ORF set was compared to every other ORF in the
set; if an ORF pair’s BLAST alignment had an expectation
value less than 1e
 30 and a length greater than 60% of the
length of the longer of the two ORFs, then the two ORFs were
considered to be members of the same family. A transitive
closure rule was applied to ensure that each ORF had
membership in one and only one family. In all, 23% of the
ORFs were members of families, a percentage comparable to
that seen in other eukaryotes [18]. The approach yielded 451
families, with an average of 3.27 members each; 13 of the
families have ten or more members, while the largest family
has 39 members, consisting of proteins with possible leucine-
rich repeat domains.
A striking difference between C. albicans and S. cerevisiae is
the manner in which they acquire nutrients from the
environment. In addition to the well-described secreted
aspartyl proteinases, lipases, and high-afﬁnity iron trans-
porters, C. albicans possesses expanded families of acid
sphingomyelinases (with four genes per haploid genome),
phospholipases B (six genes), oligopeptide transporters (seven
genes), and amino acid permeases (23–24 genes). Another
striking difference is the emphasis by C. albicans on
respiratory catabolism, as reﬂected in expanded families of
peroxisomal enzymes. These include families of acyl-CoA
oxidases (three genes), 3-ketoacyl-CoA thiolases (four genes),
acyl-CoA thioesterases (three or four genes), fatty acid–CoA
synthases (ﬁve genes), and glutathione peroxidases (four
genes).
Additional families that may pertain to colonization or
pathogenesis include those encoding the estrogen-binding
protein OYE1 (seven genes), the ﬂuconazole-resistance trans-
porter FLU1 (13 genes), and the vacuolar protein PEP3/VPS16
(four genes), whose Aspergillus homolog is required for
nuclear migration and polarized growth.
The ATP-binding cassette transporter superfamily. The
ATP-binding cassette (ABC) protein superfamily represents
one of the largest protein families known to date among
available genome sequences. These proteins share similar
molecular architecture with the presence of at least one
conserved ABC domain and the presence of membrane-
spanning segments (transmembrane segments [TMSs]). The
ABC domain typically contains Walker A and Walker B motifs
and an ABC signature motif. The ABC domain and TMSs can
be arranged in a duplicated forward (TMS6-ABC)2 or reverse
(ABC-TMS6)2 topology, however ‘‘half size’’ ABC proteins also
exist. As indicated in Table 6, the C. albicans genome contains
at least 27 genes with ABC domains that include these
topologies. These genes have been categorized, according to a
classiﬁcation established in S. cerevisiae, into six subfamilies
(the MDR, PDR, MRP/CFTR, ALD, YEF3, and RLI subfamilies)
[42]. The MDR, PDR, MRP/CFTR, and ALD subfamilies likely
all encode transporter proteins, while the other subfamilies,
YEF3 and RLI, generally lack TMSs and are considered as
non-transporter ABC proteins. The C. albicans ABC proteins
fall neatly into the categories developed for S. cerevisiae, and
they are also present in approximately the same numbers
(with the exception of the MRP/CFTR subfamily; see below).
The predicted topology of each protein detailed in Table 6 is
also largely comparable between the two yeast species.
Among the 27 ABC proteins so far identiﬁed in C. albicans,
the functions of only nine have been previously character-
ized. The largest group of known ABC transporters belongs to
the CDR gene family, among which are CDR1 and CDR2, two
genes upregulated in azole-resistant clinical isolates that
function in multidrug resistance [43–45]. CDR3 and CDR4
have been shown to function as phospholipid ﬂippases and
their expression is controlled by the white–opaque switching
system [46,47]. Four MRP/CFTR-like transporters are present
in C. albicans, and among them three show the NH2-terminal
extension with additional transmembrane segments that is
typical for many MRP-like transporters (see Table 6). For
unknown reasons, homologs of additional members of this
family, such as the S. cerevisiae genes ScYBT1, ScNFT1, and
ScVMR1, are lacking in C. albicans [42,48]. Interestingly, the
vacuolar MRP-like transporter encoded by MLT1 has been
implicated in virulence [49]. Since MRP/CFTR transporters
are often involved in detoxiﬁcation of heavy metals or
xenobiotics, the presence or absence of discontinuous alleles
of some ABC transporter genes (e.g., orf19.6383) may indicate
strain differences in ABC transporter function and resulting
susceptibility to environmental stresses. Most of the ABC
transporter genes listed in Table 6 were given names through
their closest homologs in S. cerevisiae; however, the functional
assignments of these genes awaits further investigation.
The ALS family. The ALS genes encode large cell-surface
glycoproteins that function in host–pathogen interactions
[50,51]. The ALS genes are composed of three domains: a 59
domain that is approximately 1,300 bp in length and
relatively conserved in sequence across the family, a central
domain composed entirely of tandemly repeated copies of a
108-bp sequence, and a 39 domain of variable length and
sequence that encodes a serine/threonine-rich portion of the
protein [50]. Efforts to characterize the ALS genes started
independently of the C. albicans genome project [38,52–54])
and were aided greatly by information that emerged as the
genome sequencing effort progressed [55–57]. Table 7 lists
the current ORFs that correspond to genes in the ALS family.
The ALS family includes eight different genes [55], each with
an extensive degree of allelic variability, sometimes within a
given strain (Table 7) or across the wider population of C.
albicans isolates [58–60]. Because of sequence assembly
difﬁculties, mainly attributable to the length and repetitive
nature of sequences within the ALS central domain, only
three of ALS ORFs in this project are in agreement with ALS
gene sequences derived independently of the genome project
and reported in the literature (Table 7). The annotation
effort described here did not edit the underlying assembly 19
sequence. However, gap sequencing that is presently being
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will correct these errors. Published ALS gene sequences can
be found on the CGD Web site.
Assembly of the C. albicans genome sequence revealed the
contiguous positions of ALS5, ALS1, and ALS9 on Chromo-
some 6, which was veriﬁed by independent studies [57].
Additional testing revealed that, in SC5314, the large alleles
of ALS5, ALS1, and ALS9 occupy the same chromosome while
the small alleles of each gene are found on the homologous
chromosome [57]. But allelic variability and arrangement on
homologous chromosomes will vary for each C. albicans strain.
Allelic variation can be extreme for ALS genes, and is most
Table 6. Genes Encoding Members of the ABC Transporter Family
ORF Subfamily
a Topology Contig
Length
(Base Pairs)
Suggested or
Published Name
b Product/Note References
orf19.6000 PDR (ABC-TMS6)2 Contig19–10236 1,502 CDR1
ABC transporter, multidrug
resistance protein
43
orf19.5958 PDR (ABC-TMS6)2 Contig19–10236 1,500 CDR2
ABC transporter, multidrug
resistance protein
45
orf19.1313 PDR (ABC-TMS6)2 Contig19–10109 1,501 CDR3
ABC transporter, opaque-specific,
merged with orf19.1312
41,130
orf19.5079 PDR (ABC-TMS6)2 Contig19–10218 1,491 CDR4 ABC transporter, white-specific 41,131
orf19.918 PDR (ABC-TMS6)2 Contig19–10079 1,513 CDR5
ABC transporter, merged with
orf19.919
—
orf19.5759 PDR (ABC-TMS6)2 Contig19–10233 1,496 SNQ2 ABC transporter —
orf19.3120 PDR ABC-TMS6 Contig19–10166 580 orf19.3120
Possible half-size ABC transporter,
best similarity with YOL075c
—
orf19.4531 PDR TMS7-ABC-TMS6-ABC Contig19–10209 1,275 orf19.4531
ABC transporter, best similarity
withYOL075c
—
orf19.459 PDR TMS2-ABC-TMS7 Contig19–10052 1,039 ADP1 ABC transporter —
orf19.1077 MDR TMS6-ABC Contig19–10090 751 ATM1
ABC transporter, putative half-size
mitochondrial transporter
—
orf19.2615 MDR TMS6-ABC Contig19–10151 685 MDL1
ABC transporter, putative half-size
mitochondrial transporter
—
orf19.13043 MDR TMS6-ABC Contig19–20230 783 MDL2
ABC transporter, putative half-size
mitochondrial transporter, fragmented
allele orf19.5599–orf19.5600
—
orf19.7440 MDR (TMS6-ABC)2 Contig19–2514 1,324 HST6
ABC transporter, putative pheromone
transporter
132
orf19.1783 MRP/CFTR (TMS6-ABC)2 Contig19–10125 1,487 YOR1
ABC transporter, closely related to
S. cerevisiae YOR1 transporter, merged
with orf19.1784, continuous allele sequence
not confirmed
133
orf19.5100 MRP/CFTR TMS5-(TMS6-ABC)2 Contig19–10218 1,606 MLT1
Vacuolar ABC transporter, best similarity
with ScBPT1
49
orf19.6383 MRP/CFTR TMS5-(TMS6-ABC)2 Contig19–10247 1,490 orf19.6383
ABC transporter, merged with orf19.6382,
continuous allele sequence confirmed in
some strains, best similarity with ScBPT1
G. Ko ¨hler,
unpublished
orf19.6478 MRP/CFTR TMS5-(TMS6-ABC)2 Contig19–10248 1,581 YCF1
ABC transporter, closely related to
S. cerevisiae YCF1 transporter
—
orf19.7500 ALD TMS6-ABC Contig19–2516 769 PXA1
ABC transporter, putative half-size
peroxisomal transporter
—
orf19.5255 ALD TMS6-ABC Contig19–10223 668 PXA2
ABC transporter, putative half-size
peroxisomal transporter
—
orf19.2183 YEF3 ABC2 Contig19–10141 610 KRE30
Non-transporter ABC protein, best
similarity with YER036c
—
orf19.4152 YEF3 ABC2 Contig19–10198 1,051 CEF3
Non-transporter ABC protein, translation
elongation factor 3
134
orf19.6060 YEF3 ABC2 Contig19–10237 752 GCN20
Non-transporter ABC protein, best
similarity with YFR009w
—
orf19.7332 YEF3 ABC2 Contig19–2511 1,196 ELF1
Non-transporter ABC protein,
elongation-like factor
135
orf19.3034 RLI ABC2 Contig19–10163 623 RLI1
Non-transporter ABC protein, best
similarity with YDR091c
—
orf19.388 Others ABC Contig19–10051 321 CAF16
Non-transporter ABC protein, best
similarity with YFL028c
—
orf19.5029 Others ABC Contig19–10216 546 orf19.5029
Non-transporter ABC protein, best
similarity with YDR061w
—
aSubfamily nomenclature as proposed by Bauer et al. [42].
bPublished names are underlined.
DOI: 10.1371/journal.pgen.0010001.t006
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Annotation of the Candida albicans Genomecommonly associated with the tandem repeat domain,
although it is also present within other domains of the
coding region [56,57,59]. Presenting the sequence of a single
ALS allele, as done in these annotation data, loses the sense of
allelic diversity that can have a signiﬁcant effect on
evaluation of ALS protein function. For example, testing
the two ALS3 alleles from strain SC5314 in a common
adhesion assay format showed that the allele with more
Table 7. Assembly 19 ORFs That Correspond to ALS Genes
Systematic
ID
Gene
Name
Number
of Tandem
Repeat
Copies
per Allele
Method for
Determining
Repeat Copy
Number Reference Comments
orf19.5741 ALS1 8, 20 Southern blot 52
This ORF has about ten copies of the tandem repeat sequence. This number is
too large for the small ALS1 allele in strain SC5314 and far too small for the large
ALS1 allele. Some sequences from within the tandem repeat domain must have
been assembled incorrectly.
orf19.2355 ALS2 31, 36 Southern blot
L. L. Hoyer,
unpublished
This ORF encodes about 24 copies of the tandem repeat sequence, making it too
short to be either allele from strain SC5314. However, the remainder of the cod-
ing region is intact and correctly assigned as ALS2.
orf19.1816 ALS3 9, 12 DNA sequencing 57
This ORF is missing the 39 end of the coding region. The ORF has almost 12 co-
pies of the tandem repeat sequence and corresponds to the large ALS3 allele in
strain SC5314. Its name should be ALS3–1. DNA sequences of both ALS3 alleles
were derived outside of the genome sequencing effort and are available in Gen-
Bank (ALS3–1 accession number AY223552; ALS3–2 accession number AY223551).
orf19.1097 ALS4 18, 36 Southern blot
L. L. Hoyer,
unpublished
This sequence contains about 48 copies of the tandem repeat sequence. ALS4 al-
lele sizes in strain SC5314 are estimated by Southern blot to have 18 or 36 copies
of the repeated sequence. The ORF is missing the 39 end of the gene. It is possi-
ble that this ORF has the 59 end of ALS4 fused to the 39 end of ALS2.
orf19.2121 ALS4 18, 36 Southern blot
L. L. Hoyer,
unpublished
This ORF starts at amino acid 252 of the ALS4 sequence and contains about 20
copies of the tandem repeat sequence. Since the Southern blotting method, by
which ALS4 alleles sizes were judged, has some error, it is possible that this se-
quence is the smaller SC5314 allele, ALS4–2. There is a stop codon in the middle
of the sequence due to a frameshift that reads HHL* and then resumes with the
correct APSTET sequence. A DNA sequence for ALS4–2 is available in GenBank
(accession number AF272027) and includes 20 tandem repeat copies.
orf19.4555 ALS4 18, 36 Southern blot
L. L. Hoyer,
unpublished
This ORF encodes about 36 copies of the tandem repeat sequence, which is the
correct number for the larger ALS4 allele (ALS4–1) from strain SC5314. The ORF
has a frame shift within the tandem repeat domain that prematurely truncates a
repeat copy and adds ETSKLHGYHN*. The reading frame then resumes with an-
other repeat copy, but in the middle of the consensus sequence.
orf19.5736 ALS5 4, 5
PCR/acrylamide
gel; DNA
sequencing
of both alleles
L. L. Hoyer,
unpublished
This ORF contains about four copies of the tandem repeat sequence, and repre-
sents the small ALS5 allele (ALS5–2) from strain SC5314. ALS5–2 is found on the
same chromosome as the short allele of ALS1 (ALS1–2) and the short allele of
ALS9 (ALS9–2). The sequence of ALS5–2 was derived independently of the gen-
ome project and is deposited in GenBank (accession number AY227439). The se-
quence of the large ALS5 allele (ALS5–1) has GenBank accession number
AY227440.
orf19.7414 ALS6 4, 4
PCR/acrylamide
gel; DNA sequence
of one allele
L. L. Hoyer,
unpublished
The corresponding sequence from strain SC5314 is GenBank accession number
AY225310, which was derived independently of the genome sequencing project.
Both ALS6 alleles in strain SC5314 have the same number of tandem repeat co-
pies.
orf19.7400 ALS7 15, 15
PCR and genome
sequence
59
This ORF has about 15 copies of the tandem repeat sequence, which is correct
for both alleles from strain SC5314.
orf19.5742 ALS9–1 14, 17 DNA sequencing 57
This ORF should be ALS9–1 as defined by Zhao et al. [57] but has the wrong 59
end matched with the correct ALS9–1 39 end. The correct sequence for ALS9–1
from strain SC5314 is GenBank accession number AY269423. ALS9–1 should be
on the same chromosome copy as ALS1–1 and ALS5–1. Separate alleles of ALS1
and ALS5 were not maintained in the genome assembly process.
orf19.45 ALS9–2 14, 17 DNA sequencing 57
The closest match to this ORF is ALS9–2, but this ORF is only a partial sequence.
It is likely that the rest of ALS9–2 was collapsed into ALS9–1 and this sequence is
left since it does not directly match ALS9–1.T h eALS9–2 sequence should be on
the same chromosome copy as ALS1–2 (closest match is orf19–5741) and ALS5–2
(orf19.5736). The correct sequence for ALS9–2 in SC5314 is GenBank accession
number AY269422.
orf19.79 Unknown 50
This ORF is composed entirely of tandem repeat sequences that come from ALS1,
ALS2, ALS3, or ALS4. These four genes have tandem repeat sequences that cross-
hybridize by Southern blotting and comprise one subfamily of the ALS genes.
DOI: 10.1371/journal.pgen.0010001.t007
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Annotation of the Candida albicans Genometandem repeat copies produced a protein with greater
adhesive capability than the smaller allele [60]. Table 7 notes
GenBank entries for ALS alleles from strain SC5314 that aid
understanding of allelic diversity for the various ALS genes.
The MEP family. Members of the MEP gene family encode
ammonium permeases and, along with the OPT family
described below, feature prominently in our list of fungal-
speciﬁc genes. They thus represent potentially interesting
targets for the development of antifungal drugs. Experimen-
tal evidence suggests that MEP1 and MEP2 encode the only
speciﬁc ammonium permeases in C. albicans, since Dmep1
Dmep2 double mutants exhibited no detectable ammonium
uptake and were unable to grow at ammonium concentra-
tions below 5 mM [61], a phenotype that is similar to that of S.
cerevisiae mutants deleted for all three ammonium permeases
[62,63]. The third C. albicans gene, represented by orf19.4446,
encodes a protein with much lower similarity to the other
ammonium permeases of C. albicans and S. cerevisiae (approx-
imately 44% to all proteins) but might encode an ammonium
permease that is not expressed under the growth conditions
used in these assays.
In addition to its role in ammonium transport, Mep2p also
controls nitrogen-starvation-induced ﬁlamentous growth of
C. albicans. Mutants in which only the MEP2 gene was deleted
grew as well as the wild-type strain at low ammonium
concentrations but failed to ﬁlament under these conditions.
This role of MEP2 in ﬁlamentous growth of C. albicans at low
ammonium concentrations is similar to the function of its
counterpart ScMEP2 in pseudohyphal growth of S. cerevisiae
under limiting ammonium conditions [63]. However, in
contrast to the latter, MEP2 seems to have a much broader
role in ﬁlamentous growth of C. albicans since Dmep2 mutants
also had a ﬁlamentation defect when amino acids or urea
instead of ammonium served as the limiting nitrogen source
(J. Morschha ¨user, personal communication).
The OPT family. Oligopeptide transporters represent
another group of fungal-speciﬁc surface proteins that trans-
port peptides of four or ﬁve amino acids in length into the
cell and together with the di- and tripetide transporters allow
growth when peptides are the only available nitrogen source.
This is presumably the position of C. albicans cells when they
have invaded host tissues and are secreting their battery of
peptidases and other catabolic enzymes. The founding
member of the oligopeptide transporter gene family was
OPT1 from C. albicans [64]. Analysis of the C. albicans genome
sequence as well as cloning of the corresponding genes
demonstrated that C. albicans in fact possesses a large gene
family encoding putative oligopeptide transporters. The OPT
genes were annotated according to their decreasing similarity
to OPT1. The OPT2, OPT3, and OPT4 genes are highly similar
to each other. The similarity of the remaining members of the
family then drops considerably, but we have detected genes
now named OPT6, OPT7, and OPT8. Deletion of the OPT1
alleles in the C. albicans wild-type strain SC5314 resulted in
increased resistance of the mutants to a toxic tetrapeptide,
providing experimental evidence that Opt1p indeed func-
tions as an oligopeptide transporter in C. albicans [65].
Preliminary observations indicate that at least the OPT2 to
OPT5 genes also encode functional oligopeptide transporters
(O. Reuß and J. Morschha ¨user, unpublished data).
Zinc cluster transcription factors. Proteins of the zinc
ﬁnger superfamily represent one of the largest classes of
DNA-binding proteins in eukaryotes. Several different classes
of zinc ﬁnger domains exist that differ in the arrangement of
their zinc-binding residues [66]. One of these domains, which
appears to be restricted to fungi, consists of the Zn(II)2Cys6
binuclear cluster motif in which six cysteines coordinate two
zinc atoms [67,68]. S. cerevisiae possesses 54 zinc cluster factors
deﬁned by the presence of the zinc cluster signature motif
CX2CX6CX5–16CX2CX6–8C, which is generally located at the
N-terminus of the protein. These proteins function as
transcriptional regulators involved in various cellular pro-
cesses including primary and secondary metabolism (e.g.,
Gal4p, Ppr1p, Hap1p, Cha4p, Leu3p, Lys14p, and Cat8p),
pleiotropic drug resistance (e.g., Pdr1p, Pdr3p, and Yrr1p),
and meiosis (Ume6p) [68,69]. Quite often, they bind as homo-
or heterodimers to two CGG triplets organized as direct,
indirect, or inverted repeats and separated by sequences of
variable length [68,70]. A large proportion of these factors
(50%) also contain a middle homology region (Fungal_trans
in the Pfam Protein Families Database) located in the central
portion of the protein that has been proposed to participate
in DNA binding and to assist in DNA target discrimination
[67].
Analysis of the C. albicans proteome using a combination of
sequence analyses tools (SMART, Pfam, and PHI-BLAST)
allowed us to identify 77 binuclear cluster proteins. These
factors are characterized by the presence of the zinc cluster
signature motif CX2CX6CX5–24CX2CX6–9C generally located
at the N-terminus of the protein (72 out of 77) and with a
spacing between cysteines 3–4 and 5–6 slightly different from
the S. cerevisiae motif. As observed in S. cerevisiae, a large
proportion of the C. albicans factors also contain a middle
homology region (29 out of 77). To our knowledge, only six of
the C. albicans zinc cluster genes have been characterized in
detail, including SUC1, involved in sucrose utilization [71],
FCR1, implicated in pleiotropic drug resistance [72], CWT1,
required for cell wall integrity [73], and CZF1, FGR17, and
FGR27, involved in ﬁlamentous growth [9,74]. The functions
of many uncharacterized C. albicans zinc cluster factors
(approximately 20%) can be inferred from the fact that they
display high levels of sequence similarity (top BLASTP e-value
  1e
 20) with the products of S. cerevisiae genes with a known
function. In the case of GAL4, however, the C. albicans
homologous ORF identiﬁed (orf19.5338) encodes a signiﬁ-
cantly smaller protein (261 aa) than S. cerevisiae Gal4p (881 aa),
lacking the C-terminal two-thirds of the protein that contains
one of two transcriptional activating domains, and must
therefore have a somewhat different function. Approximately
half of the C. albicans zinc cluster genes do not appear to have
homologs in S. cerevisiae (using a BLAST cutoff of , 1e
 20) and
are therefore likely to participate in processes speciﬁc to C.
albicans. Finally, it is noteworthy that many of the zinc cluster
factors known to be involved in pleiotropic drug resistance in
S. cerevisiae, such as Pdr1p, Pdr3p, Yrr1p, Yrm1p, Rds1p, and
Rdr1p, do not appear to possess close structural homologs in
C. albicans. Since pleiotropic drug resistance is frequently
observed in C. albicans, it is likely that this organism possesses
functional homologs of these genes or other novel processes
that remain to be identiﬁed.
Lipid and Amino Acid Metabolism
Some of the C. albicans ORFs that do not have clear
homologs in S. cerevisiae but do have homologs in other fungi,
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oxidoreductases, and proteins involved in environmental
sensing pathways. The list of genes that C. albicans does not
share with S. cerevisiae is skewed towards enzymes involved in
the catabolism of fatty acids and ketone bodies in the
peroxisome. There are also numerous oxidoreductases, some
of which may be involved in activating hydrophobic organic
compounds as a prelude to their oxidative degradation. This
metabolic arrangement may reﬂect, in part, the state of the
common ancestor with S. cerevisiae, as also reﬂected in
Yarrowia lipolytica, C. antartica, C. rugosa, C. tropicalis, C. maltosa,
and C. deformans, which are model organisms in the study of
lipases and alkane oxidation for industrial purposes. It is
worth mentioning, however, that the genus Candida arose
originally to identify fungi that were unclassiﬁable, asexual,
and ascomycetous—properties that appear to correlate with
parasitism and the presence of catabolic gene families, such
as lipases and alkane-assimilating cytochrome P-450 enzymes.
Beta-oxidation in fungi is predominantly peroxisomal, and
the number of enzymes participating in the process is greater
in C. albicans than in S. cerevisiae. C. albicans also encodes a
related ethanolamine kinase (orf19.6912), a malonyl-CoA acyl
carrier protein acyltransferase (MCT1), and an enoyl-CoA
hydratase (orf19.6830) not found in S. cerevisiae. Further
supplying substrates for oxidation are several enzymes
encoded by C. albicans that participate in the degradation of
asparagine (asparaginase; orf19.3791), cysteine (cysteine
dioxygenase [CDG1] and cysteine sulﬁnate decarboxylase
[orf19.5393]), valine (3-hydroxyisobutyrate dehydrogenase
[orf19.5565]), and arginine (orf19.3498). Other catabolic
enzymes come as a surprise in that they may relate to the
scavenging of unsuspected carbon sources. C. albicans encodes
three D-amino acid oxidases (IFG3, DAO1, and DAO2) whose
substrates might be derived from bacterial cell walls, various
oxidoreductases whose substrates are likely to be aromatic
and aliphatic compounds not used by the host, a pathway
consistent with omega oxidation of fatty acids (which would
convert alkanes into alpha-omega diols, fatty acids, and
dicarboxylic acids), and a benzene desulfurase (orf19.3901).
Acetyl-CoA generated in the peroxisome is transferred to
the mitochondrion, where the most notable difference from
S. cerevisiae is the presence of a respiratory Complex I, which
can now largely be reconstructed based on sequence
similarity to components found in other organisms. The
importance of Complex I in the biology of C. albicans is
inferred from the observation that deletion of one of its
subunits results in a defect in ﬁlamentation [75] and the
observation that subunit 49 is essential for vegetative growth
[8]. An additional difference is the presence of two alternative
oxidases that may be involved in protection against oxidative
stress [76]. Thus, it is not yet clear whether the omnivorous
catabolic capacity of C. albicans reﬂects its heritage and role as
a fungal saprophyte aiding organic decomposition, or
whether these capacities have been elaborated and tuned in
response to the speciﬁc problem of consuming mammalian
host cells.
Phospholipases. Depending on the site of attack, phospho-
lipases are classiﬁed as phospholipase A, B, C, or D.
Phospholipase A enzymes hydrolyze the 1-acyl ester (PLA1)
or the 2-acyl ester (PLA2) of phospholipids. In fungi,
phospholipase B enzymes hydrolyze both acyl groups and
often also have lysophospholipase activity, removing the
remaining acyl moiety on lysophospholipids [77]. Phospholi-
pase C and phospholipase D enzymes are phosphodiesterases
that cleave the glycerophosphate bond and remove the base
group of phospholipids, respectively. While a major role of
phospholipase function is membrane homeostasis, additional
functions comprise nutrient digestion and generation of
signaling molecules. Some phospholipases are toxins or
components of venoms. Bacterial phospholipases have been
shown to be involved in pathogenesis by promoting hemol-
ysis, cytolysis, and tissue destruction, as well as interfering
with host signal transduction [78].
As indicated in Table 8, the largest and best-characterized
group of phospholipases in C. albicans is the ﬁve-member
phospholipase B gene family. A related gene family is present
in S. cerevisiae, albeit with three members, again reﬂecting the
general increase in gene numbers for enzymes involved in
lipid metabolism in C. albicans. All PLB proteins harbor NH2-
terminal signal peptides for secretion; Plb3p, Plb4p, and
Plb5p additionally contain hydrophobic COOH termini with
putative GPI anchor attachment sites for localization to the
plasma membrane or further processing for tethering to the
cell wall [79,80]. To date, PLB1 and PLB2 are the best-
characterized members of the gene family [81–84]. Inactiva-
tion of PLB1 [82,83] and PLB5 (S. Theiss, G. Ishdorj, M.
Kretschman, C. Y. Lan, T. Nichterlein, et al., unpublished
data) reduced virulence in animal models.
Putative PLC and PLD phosphodiesterases are also
represented in the C. albicans genome. Orf19.6629 is a likely
homolog to S. cerevisiae ScISC1, which encodes a PLC with
neutral sphingomyelinase activity. Besides the recently
published PLC1 gene [85], two almost identical genes encode
phosphatidylinositol phospholipase C proteins (PI-PLC). The
latter lack homologs in S. cerevisiae, but are similar to bacterial
PI-PLCs. PLD1 was shown to be involved in the morpho-
logical transition from yeast to hyphae and required for full
virulence in animal models [86]. Interestingly, the PLD1 gene
product and another phospholipase-like protein (encoded by
orf19.4151) show signiﬁcant sequence similarity to S. cerevisiae
proteins that are involved in meiosis and sporulation
(ScSpo1p, ScSpo14p, and ScSpo22p). As already shown for
PLD1, the ScSPO1 homolog, the functional roles of these
proteins are likely to differ from their counterparts in S.
cerevisiae since C. albicans has not been shown to undergo
meiosis [10].
Another intriguing group of phospholipase genes in C.
albicans are patatin-like phospholipases encoded by
orf19.1504, orf19.5426, and orf19.6396. These proteins might
account for phospholipase A activities in C. albicans that could
be involved in intracellular storage or mobilization of lipids.
Sphingolipid metabolism. C. albicans also displays differ-
ences from S. cerevisiae with respect to sphingolipid metabo-
lism. Pathways leading to and from fungal-type
sphingomyelins have been studied extensively in S. cerevisiae,
where by-products mediate many important structural and
signaling functions that affect cell proliferation, the deﬁni-
tion of cell membrane domains and polarity, apoptosis, and
stress responses [87,88]. Many of the associated enzymes are
essential and are targets of fungal toxins, and thus are
candidates for anti-fungal drug development [88]. C. albicans
shares the same fundamental pathways in sphingolipid
biosynthesis/degradation plus four additional enzymes. Two
of these, a glucosyl transferase (CGT1) and a delta-4
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The presence of glycosyl ceramides in C. albicans has been
known for some time [89,90], and the gene responsible for
their synthesis has been cloned and expressed in Pichia [91].
The molecules play a common role in differentiation in
dimorphic fungi [92]. Homologs of the delta-4 sphingolipid
desaturase enzyme include the mouse, human, and Drosophila
degenerative spermatocyte proteins, which play a role in
meiosis [93]; its function in C. albicans may relate to
membrane structure, or the production of signaling mole-
cules, as is the case in plants. An interesting component of
sphingolipid metabolism in C. albicans is a sphingomyelin
transfer protein (Het1p) similar to the Podospora anserina
HET-C2 protein. The P. anserina protein is involved in self/
non-self discrimination, a fungal version of the vertebrate
major histocompatibility locus [94,95]. It is possible that the
protein is involved in regulating the sphingomyelin compo-
sition of C. albicans membranes, a factor that may relate to
acquisition of resistance to amphotericin B and azoles [96].
Finally, C. albicans encodes four acid sphingomyelinases, two
of which may be secreted, that have not been studied in fungi.
Based on the actions of metazoan secreted acid sphingomye-
linases, these enzymes may be involved in regulation of
membrane raft formation and generation of ceramide, a
second messenger that is known to regulate apoptosis in
higher eukaryotes. Secreted sphingomyelinases of pathogenic
bacteria, which are enzymatically similar but structurally
unrelated to those of C. albicans, have been shown to lyse
phagosomal membranes [97], facilitate entry into both
phagocytic and nonphagocytic cells [98,99], act as hemolysins
that abet piracy of iron from the host [100,101], and induce
host cell apoptosis [102,103].
Signal Transduction
Differences in signal transduction and regulatory pathways
between C. albicans and S. cerevisiae are numerous. Many of
these C. albicans–speciﬁc genes encode proteins that are
responsive to changes in the environment. They may thus be
responsive to colonization of a new anatomical site (e.g.,
passage through the stomach), ﬂuctuations in the availability
of nutrients, or the appearance of host inﬂammatory
reactions. Gene products falling into this category include
(1) a homolog (TIP120) of a TBP-interacting protein in
humans and rats, which acts as global regulator of class I, II,
Table 8. Phospholipases in C. albicans
ORF Domain (Pfam) Contig
Length
(Base Pairs)
Suggested Name/
Published Name
a Product/Note References
orf19.689
Lysophospholipase
catalytic domain
Contig19_10064 605 PLB1 Phospholipase B, gene in tandem with PLB2 81–83
orf19.690
Lysophospholipase
catalytic domain
Contig19_10064 609 PLB2 Phospholipase B, gene in tandem with PLB1 84
orf19.1442
Lysophospholipase
catalytic domain
Contig19_10119 702 PLB3
Phospholipase B, merged with orf19.1443,
continuous allele sequence confirmed
G. Ko ¨hler,
unpublished
orf19.6594
Lysophospholipase
catalytic domain
Contig19_2449 632 PLB4 Phospholipase B
orf19.5102
Lysophospholipase
catalytic domain
Contig19_10218 754 PLB5 Phospholipase B
G. Ko ¨hler,
unpublished
orf19.4151
Lysophospholipase
catalytic domain
Contig19_10198 684 SPO1
Similar to S. cerevisiae SPO1 product, a
meiosis-specific protein with similarity to
phospholipase B
orf19.5506
Phosphatidylinositol-specific
phospholipase C, X and Y domain
Contig19_2335 1,100 PLC1 Phospholipase C 85
orf19.5797
Phosphatidylinositol-specific
phospholipase C, X domain
Contig19_10234 295 PLC2/PI-PLC
Phosphatidylinositol phospholipase C,
closely related to bacterial PI-PLCs, highly
similar to orf19.1586 protein
136
orf19.1586
Phosphatidylinositol-specific
phospholipase C, X domain
Contig19_10119 295 PLC3/PI-PLC
Phosphatidylinositol phospholipase C,
closely related to bacterial PI-PLCs, highly
similar to orf19.5797 protein
orf19.6629
Endonuclease/exonuclease/
phosphatase family
Contig19_10251 438 ISC1
Similar to S. cerevisiae YER019w product,
an inositol phosphosphingolipid phospholipase C
orf19.1161 Phospholipase D Contig19_10097 1,710 PLD1
Phospholipase D, similar to S. cerevisiae
SPO14 product which is required for
meiosis and spore formation
86,137
orf19.1504 Patatin-like phospholipase Contig19_10119 853 orf19.1504
Potential patatin-like phospholipase similar
to Sc. pombe SPAC31G5.20c and to
S. cerevisiae YOR081c
orf19.5426 Patatin-like phospholipase Contig19_10227 949 orf19.5426
Potential patatin-like phospholipase similar
to S. cerevisiae YKR089c
orf19.6396 Patatin-like phospholipase Contig19_10247 1,386 orf19.6396
Potential patatin-like phospholipase with
cyclic nucleotide binding domain, similar
to S. cerevisiae YML059c
orf19.13603 Contig19_20241 835 SPO22
Similar to S. cerevisiae SPO22 product,
a meiosis-specific phospholipase A2 homolog
aPublished names are underlined.
DOI: 10.1371/journal.pgen.0010001.t008
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conditions [104], (2) a relative (orf 19.1798) of tuberin, a
negative regulator of cell growth in response to low cellular
energy levels in mammals [105], (3) a conserved group of
stomatin-like proteins (orf 19.7296 and SLP2) that may play a
role in mechanoreception, (4) a family of pirin homologs that
obviously arose from a recent duplication event (PRN1,
PRN2, PRN3, and PRN4)—these are nuclear factors whose
homologs interact with the human oncogene Bcl-3 product
and with an A. thaliana G protein alpha-subunit involved in
regulating seed germination and early seedling development
[106])—and (5) a rhomboid protein (orf 19.5234), probably
located on the plasma membrane, whose homologs in
eukaryotes and bacteria mediate the proteolytic release of
signaling peptides from a larger precursor [107]. In addition
to differences traceable to novel genes, other pathways that
share components have doubtless been altered in their role
and regulation, such as the mating pathway [108].
Two of the most important enzyme families that are
involved in signal transduction pathways are the kinases and
small GTPases. The C. albicans annotation identiﬁes 96
protein kinases, most of which have strong orthologs in S.
cerevisiae. The C. albicans genome contains two genes encoding
GTPases of the heterotrimeric G protein alpha-subunit
family—GPA1 and GPA2. In addition, it contains 29 small
GTPases of the p21 superfamily. These include a single Ras
protein (Ras1p), various members of the Rho and Rab
families, the Ran1 homolog Gsp1p, and several members of
the ADP ribosylation subfamily. Most of these proteins have
clear S. cerevisiae orthologs. However, S. cerevisiae does not have
a Rac homolog, while orf19.6237 appears to encode a C.
albicans Rac protein and has thus been named RAC1. As well,
orf19.5902 appears to be distantly related to Ras but lacks any
strong equivalent in any organism, and has been designated
Rlp1p, for Ras-like protein, while orf19.2975 is a YPT/RAB
family member that has been named RAB7 because it has no
clear S. cerevisiae YPT ortholog.
Conclusions
We have coordinated a community-wide effort to manually
conﬁrm, edit, and annotate 6,354 genes from assembly 19 of
the C. albicans genome. This annotation includes 214 intron-
containing genes, 246 genes with either missense mutations
or sequencing errors, and 190 truncated genes that terminate
at the ends of the sequence contigs. C. albicans genes were
found to be exceptionally rich in short sequence repeats,
especially compared to the genomes of S. pombe and S.
cerevisiae. Correlation with transcriptional proﬁling data was
used to identify potentially spurious genes. This improved
dataset allowed the identiﬁcation fungal-speciﬁc genes and
permitted a detailed analysis of several large multigene
families. Comparative genomic studies indicate that C.
albicans is much more versatile in its production of secreted
lipid- and amino-acid-degrading enzymes and in its ability to
import the resulting nutrients.
Materials and Methods
Identiﬁcation of C. albicans ORFs and merging of preliminary
annotations. Nucleotide sequence data for assembly 19 were retrieved
from the SGTC Web site (http://www-sequence.stanford.edu//group/
candida/). Assembly 19 is composed of a haploid supercontig set
(contigs 19–831 to 19–10262), here referred to as the haploid set, and
a allelic supercontig set (contigs 19–20001 to 19–20161), here referred
to as the allelic set [6].
The CAAT-Box software package [109] was used to identify
annotation-relevant ORFs in assembly orf19. A set including ORFs
longer than 300 codons and a set with all intergenic regions obtained
after subtraction of ORFs larger than 80 codons were created. These
sets were used to build a GeneMark matrix [11] that was subsequently
used to evaluate the coding probability of all ORFs in assembly 19.
ORFs longer than 150 codons, and ORFs longer than 40 codons and
with a GeneMark coding function greater than 0.5 [11] over their
whole length, were selected and assigned a reference number of the
format IPFn.i where IPF stands for individual protein ﬁle, n is an
integer speciﬁc to the IPF, and i corresponds to the number of times
the IPF has been modiﬁed between assembly 5, 6, and 19 of the C.
albicans genome sequence. In total, 11,025 and 9,089 IPFs were
selected in the haploid and allelic sets, respectively. IPFs shorter than
150 codons in the haploid set were further inspected for (1) overlaps
with larger IPFs on a different frame and (2) homology to proteins in
the NR database of non-redundant proteins from GenBank. IPFs that
overlapped with a larger IPF or did not show a signiﬁcant homolog
(BLASTP e-value , 1e
 3) [110] were designated FALSORF. Of the
11,025 IPFs identiﬁed in the haploid set, 3,505 were FALSORFs.
All IPFs identiﬁed in the haploid set were compared through
reciprocal BLASTP to the set of 7,680 C. albicans ORFs deﬁned at the
SGTC that uses the systematic designation orf19.n. BLASTP results
were parsed using Readblast [111]. IPFs without an orf19.n counter-
part were assigned a new reference number of the format orf19.n.i,
where orf19.n is the closest upstream (using SGTC contig coordi-
nates) ORF deﬁned by the SGTC and i is an integer that varies
between 1 and the number of IPFs located between orf19.n and
orf19.(n þ 1). For instance, if three ORFs were found between
orf19.1234 and orf19.1235, these would be referred to as orf19.1234.1,
orf19.1234.2, and orf19.1234.3. Taken together, 11,616 orf19 ORFs
were identiﬁed in the haploid set, of which 3,936 were not present in
the SGTC orf19 set.
A similar procedure was applied to the allelic set of sequences, and
a total of 9,552 orf19 ORFs were identiﬁed, of which 3,012 were not
present in the SGTC orf19 set. The haploid and allelic sets of orf19
ORFs were compared by reciprocal BLASTP in order to deﬁne allelic
and unique sequences in the allelic set (see below).
The 11,615 orf19 ORFs identiﬁed in the haploid set were compared
by reciprocal BLASTP to the 9,168 ORFs identiﬁed by the SGTC
using assembly 6 of the C. albicans genome sequence (designated
orf6.n). A similar reciprocal comparison was run using the set of 6,165
C. albicans proteins available in the CandidaDB database that have
been deﬁned by applying a procedure similar to that outlined above
on assembly 6 and through a manual curation aiming to reach a non-
redundant protein set (http://genolist.pasteur.fr/CandidaDB; [12]).
Furthermore, orf19 ORFs were reciprocally compared to the S.
cerevisiae proteome using data available at the SGD [112]. All data
were parsed using Readblast [111], and a matrix was generated that
correlated ORFs from each dataset.
We used the genome annotation tool Artemis [14], which provides
very detailed annotation capability, visually mapping desired features
onto the target sequence. In preparation, we loaded our heteroge-
neous data into the required EMBL-style ﬁles: (1) the orf19 reference
(ﬁeld: Assembly_ID); (2) the orf6 reference (ﬁeld: old_Assem-
bly_ID); (3) the CandidaDB entry number (ﬁeld: db_xref); (4) the
entry number for the Comprehensive Yeast Genome Database, which
provides a detailed analysis of protein features of all entries available
in CandidaDB [113] (ﬁeld: db_xref); (5) the GenBank entry number
for C. albicans proteins previously characterized and annotated (ﬁeld:
db_xref); (6) the IPF reference (ﬁeld: db_xref); (7) annotation data
available from CandidaDB (proposed gene name and proposed
function; ﬁeld: Annotator); (8) annotation data of the Agabian’s
laboratory based on the orf6 protein set (http://agabian.ucsf.edu/
canoDB/anno.php) (ﬁeld: Annotator); (9) annotation data of the
Fink’s and Johnson’s laboratories based on the orf6 protein set
(unpublished) (ﬁeld: note_AJ); (10) annotation comments available
from CandidaDB (ﬁeld: note_GF); (11) Pfam matches [114] obtained
using the orf19 protein set (ﬁeld: pfam_match); (12) Clusters of
Orthologous Groups matches [115] obtained from the Comprehen-
sive Yeast Genome Database using the CandidaDB protein set (ﬁeld:
COGs_MIPS); (13) EC number matches obtained from the Compre-
hensive Yeast Genome Database using the CandidaDB protein set
(ﬁeld: EC_number_MIPS); (14) S. cerevisiae closest protein including
e-value, putative orthology, protein function, gene name, and
alternate gene names, genome reference number obtained from
SGD (ﬁeld: Note); (15) GO annotation of the S. cerevisiae protein
obtained from SGD (ﬁeld: GO); (16) the reference of the allelic orf19
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location (ﬁeld: Allele); and (17) chromosome assignment data
available from the Magee’s and Whiteway’s laboratories (http://
206.167.190.233/candida/index.cfm?page¼CaChrom) (ﬁeld: Chromo-
some).
Furthermore all ORFs were assigned a color code in order to
facilitate annotation using the annotation tool Artemis [14]. All orf19
ORFs corresponding to an IPF classiﬁed as FALSORF and orf19 ORFs
identiﬁed at the SGTC and not found among IPFs were color-coded
in grey. orf19 ORFs with an unambiguous allele (90% identical amino
acids over the whole length of the longest ORF) were color-coded in
red (.150 codons) or pink (,150 codons). orf19 ORFs with a
questionable allele (90% identical amino acids over the whole length
of the shortest ORF) were color-coded in green (.150 codons) or pale
green (,150 codons). orf19 ORFs without a clear allele (less than 90%
identical amino acids over the whole length of the shortest ORF or no
reciprocal match) were color-coded in blue (.150 codons) or light
blue (,150 codons).
From this ‘‘master’’ ﬁle of sequences and their corresponding
preliminary annotation, groups of contigs were selected and saved as
partially annotated subsequences that were reserved and retrieved by
members of the annotation consortium, and once fully annotated,
were returned to a central Web site. A version of Artemis was
distributed to the consortium that included a modiﬁed ‘‘options’’ ﬁle
[116] allowing project-speciﬁc qualiﬁers to be used, and also featuring
the C. albicans–speciﬁc translation Table 12 [117].
Whole genome BLAST searches and visualization of sequence
homologies. ORF sequences were translated to proteins using the
translation table for C. albicans [117], and compared using the
BLASTP algorithm [118] with the NR database, the C. albicans
proteome itself, the putative proteomes of ﬁve fungi (S. cerevisiae, S.
pombe, N. crassa, A. nidulans, and M. grisea), and the proteomes of ﬁve
other eukaryotes (A. thaliana, D. melanogaster, C. elegans, M. musculus, and
H. sapiens). Sequence data were obtained from the EMBL-EBI Integr8
Browser (http://www.ebi.ac.uk/integr8/EBI-Integr8-HomePage.
do) and the Broad Institute for Genome Research (http://www.broad.
mit.edu/annotation/). For the most similar proteins by BLAST,
negative exponents of the e-values were parsed from the output ﬁles,
collected in a relational database, and visualized as a color range
associated with each reference protein (see Figure 1). For this
purpose, a Web-accessible visualization tool was constructed using
Maromedia Cold Fusion and an Apache2 Web server. These results
can be consulted at http://candida.bri.nrc.ca/candida/index.cfm?page
¼blast.
Bioinformatic identiﬁcation of putative introns. Intron locations
were predicted by constructing regular expressions based on
consensus data drawn from several known introns in C. albicans
(SOD1, EFB1, CMD1, CSK1, and others) as well as the extensive
knowledge of the splice site consensus in S. cerevisiae [119] and
matching of those expressions to the genomic DNA. Two regular
expressions were used: /(.f15,g?TG[AT]A[CT]G)/ and /(.f700g)
([ATC]TACTAAC.f4,24g?[ATC][CTA]AG)(.f90g)/. These incorporate
several conserved aspects of mRNA splice sites including (1) the splice
donor site of G(T/C)A(T/A)GT, where the initial guanine is the ﬁrst
residue within the intron, (2) a gap of between 15 and 700 nucleotides
between the donor site and the branch point, (3) the branch point
consensus sequence (A/T/C)TACTAAC, (4) a gap of between four and
24 nucleotides between the branch point and the splice acceptor site,
(5) the splice acceptor site (T/A/C)(T/A/C)AG, where the ﬁnal guanine
is the ﬁnal residue within the intron. This procedure provided
landmarks that annotators could use to decide whether a gene
contained introns, a decision also based on the position of nearby
ORFs, on the ability of the intron/exon assembly to extend the size of
the reading frame, and, most important, on the ability of the putative
intron/exon assembly to improve similarity to sequences in other
species. It predicted 1,297 introns in the C. albicans genome, many of
which were not near ORFs or were otherwise incorrect. Nevertheless,
this procedure was useful in providing markers for conﬁrmation by
the annotators.
Identiﬁcation and classiﬁcation of STRs. A STR was deﬁned as a
short nucleotide element (1–20 nt) repeated a number of times with a
periodicity P, a length L, and a tolerated mutation window W. Since
allelic indels are rare in C. albicans, we considered only mutations in
STR sequences and not insertion or deletion from the consensus
periodic pattern. W indicates the minimun distance between two
mutations within a STR. For example, the STR ‘‘CTACAACAACAG-
CAAC’’ has P ¼ 3, L ¼ 16, and W   10. When two STRs overlap they
are merged together deﬁning a single STR domain. Since short STRs
can randomly occur, depending on the G/C content of the genome,
we established a signiﬁcant threshold length LMIN for every
periodicity P and mutation window W to represent the STR length
for which the number of STR domains found in a randomized
genome is less than 5% of the number found in the real genome. We
call STR95 the set of all STR domains that are longer than the
threshold value. In the STR95 set, every STR domain has a less than
5% chance of being a random event. With this method of setting the
minimal STR length, no signiﬁcant STR can be found in any
randomized genome or in genomes that do not contain STRs in
sufﬁcient number to beat the odds 20 to one. More information and
data can be found in Dataset S6.
Identiﬁcation of spurious genes. For the calculation of gene
expression correlation, we used a set of approximately 1,000 S.
cerevisiae microarray experiments [127], and 216 genome-wide C.
albicans expression proﬁles [7,13,108,120–126]. The iterative signature
algorithm [35,127] was applied to the C. albicans expression data as
described. We analyzed ORFs present on the arrays for which an
orf19 number could be determined, including some that were
subsequently removed from the ﬁnal set of annotated genes. Pairwise
Pearson correlation coefﬁcients were calculated for each ORF with
respect to all other ORFs across all of the experiments contained in
the dataset. Random subsets of the S. cerevisiae data were generated by
randomly selecting 200 experiments from the complete set of
approximately 1,000 proﬁles. ORFs whose correlation coefﬁcient
exceeded the threshold value of 3r with at least one other ORF in the
dataset were recorded and excluded from the list of spurious gene
candidates. The standard deviation r of the background correlation
of random gene pairs was measured to be r¼0.16 for S. cerevisiae and
r ¼ 0.21 for C. albicans. Similarly, genes possessing an ortholog in S.
cerevisiae were excluded from the list of C. albicans candidates, and vice
versa. All remaining ORFs were subsequently ordered by their length,
and the 50 shortest ORFs were excluded (many of the shortest 50
genes correspond to real genes in S. cerevisiae).
Supporting Information
Dataset S1. Coordinates and All of the Annotation Fields for the
6,354 Conﬁrmed C. albicans Genes, Based on the Version 19 Genome
Assembly
Please note that Microsoft Excel may convert some of the gene names
to dates and fail to import some of the largest ﬁelds.
Found at DOI: 10.1371/journal.pgen.0010001.sd001 (2 MB TXT).
Dataset S2. Sequence and Position of All Statistically Signiﬁcant STRs
in C. albicans Coding Sequences
Found at DOI: 10.1371/journal.pgen.0010001.sd002 (291 KB TXT).
Dataset S3. Sequence and Position of All Statistically Signiﬁcant STRs
in S. pombe Coding Sequences
Found at DOI: 10.1371/journal.pgen.0010001.sd003 (11 KB TXT).
Dataset S4. Sequence and Position of All Statistically Signiﬁcant STRs
in S. cerevisiae Coding Sequences
Found at DOI: 10.1371/journal.pgen.0010001.sd004 (66 KB TXT).
Dataset S5. Sequence and Position of All Statistically Signiﬁcant STRs
in N. crassa Coding Sequences
Found at DOI: 10.1371/journal.pgen.0010001.sd005 (488 KB TXT).
Dataset S6. Detailed Description of Our STR Identiﬁcation Algorithm
Found at DOI: 10.1371/journal.pgen.0010001.sd006 (4 KB TXT).
Table S1. List of Potentially Spurious Genes
Found at DOI: 10.1371/journal.pgen.0010001.st001 (34 KB XLS).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) accession num-
bers for ORFs discussed in this paper are ALS3–1 (AY223552), ALS3–2
(AY223551), ALS4–2 (AF272027), ALS5–1 (AY227440), ALS5–2
(AY227439), strain SC5314 sequence corresponding to ALS6
(AY225310), strain SC5314 ALS9–1 (AY269423), and strain SC5314
ALS9–2 (AY269422).
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